| Pathogenicity |
In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives. |
Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S |
Molecules |
10.3390/molecules27092722 |
2022 |
* |
| Pathogenicity |
Novel axially symmetric and unsymmetric silicon(IV) phthalocyanines having anti-inflammatory groups: synthesis, characterization and their biological properties. |
Gumusgoz Celik G, Gonca S, Sahin B, Ozdemir S, Atilla D, Gurek AG |
Dalton Trans |
10.1039/d2dt00652a |
2022 |
* |
| Pathogenicity |
Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study. |
Unlu O, Bingul ES, Kesici S, Demirci M |
ADMET DMPK |
10.5599/admet.1042 |
2021 |
* |
| Pathogenicity |
Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections. |
Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N |
Nanomaterials (Basel) |
10.3390/nano12050856 |
2022 |
* |
| Enzymology |
Capillary Zone Electrophoresis in Tandem with Flow Cytometry in Viability Study of Various ATCC Bacterial Strains under Antibiotic Treatment. |
Kupczyk W, Maslak E, Railean-Plugaru V, Pomastowski P, Jackowski M, Buszewski B |
Int J Environ Res Public Health |
10.3390/ijerph19031833 |
2022 |
* |
| Pathogenicity |
Structural, biocompatibility, and antibacterial properties of Ge-DLC nanocomposite for biomedical applications. |
Arslan ME, Kurt MS, Aslan N, Kadi A, Oner S, Cobanoglu S, Yazici A |
J Biomed Mater Res B Appl Biomater |
10.1002/jbm.b.35027 |
2022 |
* |
| Pathogenicity |
eDNA Inactivation and Biofilm Inhibition by the PolymericBiocide Polyhexamethylene Guanidine Hydrochloride (PHMG-Cl). |
Moshynets OV, Baranovskyi TP, Iungin OS, Kysil NP, Metelytsia LO, Pokholenko I, Potochilova VV, Potters G, Rudnieva KL, Rymar SY, Semenyuta IV, Spiers AJ, Tarasyuk OP, Rogalsky SP |
Int J Mol Sci |
10.3390/ijms23020731 |
2022 |
* |
| Pathogenicity |
Phytochemical Profile, Antimicrobial, Cytotoxic, and Antioxidant Activities of Fresh and Air-Dried Satureja nabateorum Essential Oils. |
Al-Maharik N, Jaradat N |
Molecules |
10.3390/molecules27010125 |
2021 |
* |
| Enzymology |
Preventing Pseudomonas aeruginosa Biofilms on Indwelling Catheters by Surface-Bound Enzymes. |
Asker D, Awad TS, Raju D, Sanchez H, Lacdao I, Gilbert S, Sivarajah P, Andes DR, Sheppard DC, Howell PL, Hatton BD |
ACS Appl Bio Mater |
10.1021/acsabm.1c00794 |
2021 |
* |
| Pathogenicity |
Comparative Study of Antimicrobial, Anti-Inflammatory, and Antioxidant Activities of Different Parts from Pterocarpus Santalinoides l'Her. Ex. DC (Fabaceae). |
Ayena AC, Anani K, Dosseh K, Agbonon A, Gbeassor M |
Evid Based Complement Alternat Med |
10.1155/2021/8938534 |
2021 |
* |
| Enzymology |
Combined Application of MMT K10 Supported Copper Oxide Nanoparticles for Complete Removal of Cr(VI) from Aqueous Solution and Their Antibacterial Potential. |
Gupta MK, Tandon PK, Afroz M, Agrahari S |
Acta Chim Slov |
Gupta-2021-3 |
2021 |
* |
| Phylogeny |
Isolation, Whole-Genome Sequencing, and Annotation of Three Unclassified Antibiotic-Producing Bacteria, Enterobacter sp. Strain RIT 637, Pseudomonas sp. Strain RIT 778, and Deinococcus sp. Strain RIT 780. |
Schroeter MN, Gazali SJ, Parthasarathy A, Wadsworth CB, Miranda RR, Thomas BN, Hudson AO |
Microbiol Resour Announc |
10.1128/MRA.00863-21 |
2021 |
* |
| Pathogenicity |
Mucoadhesive silver nanoparticle-based local drug delivery system for peri-implantitis management in COVID-19 era. Part 1: antimicrobial and safety in-vitro analysis. |
Dhingra K, Dinda AK, Kottarath SK, Chaudhari PK, Verma F |
J Oral Biol Craniofac Res |
10.1016/j.jobcr.2021.11.007 |
2021 |
* |
| Pathogenicity |
Ortho-hydroxy bioactive schiff base compounds: Design, comprehensive characterization, photophysical properties and elucidation of antimicrobial and mutagenic potentials. |
Nibras Qader Qader I, Obali I, Ismet Ucan H, Uysal A, Yilmaz Obali A, Kul M |
Bioorg Chem |
10.1016/j.bioorg.2021.105507 |
2021 |
* |
| Biotechnology |
Growth Optimization of Lactobacillus acidophilus for Production of Antimicrobial Peptide Acidocin 4356: Scale up from Flask to Lab-Scale Fermenter. |
Modiri S, Kasra Kermanshahi R, Reza Soudi M, Dad N, Ebadi M, Shahbani Zahiri H, Akbari Noghabi K |
Iran J Biotechnol |
10.30498/ijb.2021.218725.2686 |
2021 |
* |
| Pathogenicity |
Novel magnetic organic-inorganic hybrids based on aromatic polyamides and ZnFe2O4 nanoparticles with biological activity. |
Eivazzadeh-Keihan R, Ghafori Gorab M, Aghamirza Moghim Aliabadi H, Mahdavi M, Akbarzadeh AR, Maleki A, Ghafuri H |
Sci Rep |
10.1038/s41598-021-99842-4 |
2021 |
* |
| Pathogenicity |
Sintered and 3D-Printed Bulks of MgB2-Based Materials with Antimicrobial Properties. |
Badica P, Batalu ND, Chifiriuc MC, Burdusel M, Grigoroscuta MA, Aldica GV, Pasuk I, Kuncser A, Popa M, Agostino A, Operti L, Padhi SK, Bonino V, Truccato M |
Molecules |
10.3390/molecules26196045 |
2021 |
* |
| Pathogenicity |
Bruguiera gymnorhiza (L.) Lam. at the Forefront of Pharma to Confront Zika Virus and Microbial Infections-An In Vitro and In Silico Perspective. |
Bibi Sadeer N, Haddad JG, Oday Ezzat M, Despres P, Abdallah HH, Zengin G, Uysal A, El Kalamouni C, Gallo M, Montesano D, Mahomoodally MF |
Molecules |
10.3390/molecules26195768 |
2021 |
* |
| Pathogenicity |
S-layer protein 2 of vaginal Lactobacillus crispatus 2029 enhances growth, differentiation, VEGF production and barrier functions in intestinal epithelial cell line Caco-2. |
Abramov VM, Kosarev IV, Priputnevich TV, Machulin AV, Abashina TN, Chikileva IO, Donetskova AD, Takada K, Melnikov VG, Vasilenko RN, Khlebnikov VS, Samoilenko VA, Nikonov IN, Sukhikh GT, Uversky VN, Karlyshev AV |
Int J Biol Macromol |
10.1016/j.ijbiomac.2021.08.150 |
2021 |
* |
| Phylogeny |
Selective Thermotolerant Lactic Acid Bacteria Isolated From Fermented Juice of Epiphytic Lactic Acid Bacteria and Their Effects on Fermentation Quality of Stylo Silages. |
Pitiwittayakul N, Bureenok S, Schonewille JT |
Front Microbiol |
10.3389/fmicb.2021.673946 |
2021 |
* |
| Pathogenicity |
Chalcogenide nanoparticles and organic photosensitizers for synergetic antimicrobial photodynamic therapy. |
Garin C, Alejo T, Perez-Laguna V, Prieto M, Mendoza G, Arruebo M, Sebastian V, Rezusta A |
J Mater Chem B |
10.1039/d1tb00972a |
2021 |
* |
| Pathogenicity |
Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides. |
Frolov NA, Fedoseeva KA, Hansford KA, Vereshchagin AN |
ChemMedChem |
10.1002/cmdc.202100284 |
2021 |
* |
| Pathogenicity |
Platelet activation and antimicrobial activity of L-PRF: a preliminary study. |
Melo-Ferraz A, Coelho C, Miller P, Criado MB, Monteiro MC |
Mol Biol Rep |
10.1007/s11033-021-06487-7 |
2021 |
* |
| Pathogenicity |
The essential oils of Grewia Lasiocarpa E. Mey. Ex Harv.: chemical composition, in vitro biological activity and cytotoxic effect on Hela cells. |
Akwu NA, Naidoo Y, Channangihalli ST, Singh M, Nundkumar N, Lin J |
An Acad Bras Cienc |
10.1590/0001-3765202120190343 |
2021 |
* |
| Pathogenicity |
Lemon Oils Attenuate the Pathogenicity of Pseudomonas aeruginosa by Quorum Sensing Inhibition. |
Luciardi MC, Blazquez MA, Alberto MR, Cartagena E, Arena ME |
Molecules |
10.3390/molecules26102863 |
2021 |
* |
| Pathogenicity |
Ag-Doped and Antibiotic-Loaded Hexagonal Boron Nitride Nanoparticles as Promising Carriers to Fight Different Pathogens. |
Gudz KY, Antipina LY, Permyakova ES, Kovalskii AM, Konopatsky AS, Filippovich SY, Dyatlov IA, Slukin PV, Ignatov SG, Shtansky DV |
ACS Appl Mater Interfaces |
10.1021/acsami.1c03775 |
2021 |
* |
| Pathogenicity |
Antibacterial composite coatings of MgB2 powders embedded in PVP matrix. |
Badica P, Batalu ND, Burdusel M, Grigoroscuta MA, Aldica G, Enculescu M, Gradisteanu Pircalabioru G, Popa M, Marutescu LG, Dumitriu BG, Olariu L, Bicu A, Purcareanu B, Operti L, Bonino V, Agostino A, Truccato M, Chifiriuc MC |
Sci Rep |
10.1038/s41598-021-88885-2 |
2021 |
* |
| Pathogenicity |
Microbiological aspects of conservative treatment of periodontal disease using gel-based preparations. |
Lyubchenko OV, Velihoria IE, Polyakova SV, Ivanov OE, Tzyhanova NB, Pushkar LY, Sirota OM, Tzyhanova IV |
Pol Merkur Lekarski |
PML290-125 |
2021 |
* |
| Phylogeny |
Antibacterial and synergistic activity of 6beta-hydroxy-3-oxolup-20(29)-en-28-oic acid (6beta-hydroxy betunolic acid) isolated from Schumacheria castaneifolia vahl. |
Wickramasingha WGD, Jayasinghe S, Karunaratne DN, Ekanayake EWMA, Liyanapathirana V, Karunaratne V |
Bioorg Med Chem |
10.1016/j.bmc.2021.116142 |
2021 |
* |
| Pathogenicity |
One-Pot Reducing Agent-Free Synthesis of Silver Nanoparticles/Nitrocellulose Composite Surface Coating with Antimicrobial and Antibiofilm Activities. |
Kumarasinghe KGUR, Silva WCH, Fernando MDA, Palliyaguru L, Jayawardena PS, Shimomura M, Fernando SSN, Gunasekara TDCP, Jayaweera PM |
Biomed Res Int |
10.1155/2021/6666642 |
2021 |
* |
| Pathogenicity |
In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50. |
Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS |
Klin Lab Diagn |
10.51620/0869-2084-2021-66-2-110-114 |
2021 |
* |
| Pathogenicity |
Dual antimicrobial and anticancer activity of a novel synthetic alpha-helical antimicrobial peptide. |
Thankappan B, Sivakumar J, Asokan S, Ramasamy M, Pillai MM, Selvakumar R, Angayarkanni J |
Eur J Pharm Sci |
10.1016/j.ejps.2021.105784 |
2021 |
* |
| Pathogenicity |
Tribological, biocompatibility, and antibiofilm properties of tungsten-germanium coating using magnetron sputtering. |
Kurt MS, Arslan ME, Yazici A, Mudu I, Arslan E |
J Mater Sci Mater Med |
10.1007/s10856-020-06477-4 |
2021 |
* |
| Phylogeny |
Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against Pseudomonas aeruginosa clinically isolated bacterial strains. |
Fadwa AO, Alkoblan DK, Mateen A, Albarag AM |
Saudi J Biol Sci |
10.1016/j.sjbs.2020.09.064 |
2020 |
* |
| Pathogenicity |
The sponges Hymeniacidon perlevis and Halichondria panicea are reservoirs of antibiotic-producing bacteria against multi-drug resistant Staphylococcus aureus. |
Rodriguez Jimenez A, Dechamps E, Giaux A, Goetghebuer L, Bauwens M, Willenz P, Flahaut S, Laport MS, George IF |
J Appl Microbiol |
10.1111/jam.14999 |
2021 |
* |
| Pathogenicity |
The Antimicrobial Activities of Silver Nanoparticles Synthesized from Medicinal Mushrooms. |
Klaus A, Petrovic P, Vunduk J, Pavlovic V, Van Griensven LJLD |
Int J Med Mushrooms |
10.1615/IntJMedMushrooms.2020035988 |
2020 |
* |
| Pathogenicity |
Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment. |
Ramzi A, Oumokhtar B, Ez Zoubi Y, Filali Mouatassem T, Benboubker M, El Ouali Lalami A |
Biomed Res Int |
10.1155/2020/6509740 |
2020 |
* |
| Pathogenicity |
Computer Program for Detection and Analyzing the Porin-Mediated Antibiotic Resistance of Bacteria. |
Savinova TA, Samchenko AA, Bocharova YA, Mayansky NA, Chebotar IV |
Sovrem Tekhnologii Med |
10.17691/stm2021.13.6.02 |
2021 |
* |
| Pathogenicity |
Inhibition of the clinical isolates of Acinetobacter baumannii by Pseudomonas aeruginosa: In vitro assessment of a case-based study. |
Huang CW, Lin YS, Huang WC, Lai CC, Chien HJ, Hu NJ, Chen JH |
J Microbiol Immunol Infect |
10.1016/j.jmii.2020.11.006 |
2020 |
* |
| Pathogenicity |
Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka. |
Green KJ, Dods K, Hammer KA |
PLoS One |
10.1371/journal.pone.0243246 |
2020 |
* |
| Pathogenicity |
Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety. |
Bazine I, Bendjedid S, Boukhari A |
Arch Pharm (Weinheim) |
10.1002/ardp.202000291 |
2020 |
* |
| Cultivation |
Use of fluorescence foldscope as an effective tool for detection of biofilm formation in Pseudomonas aeruginosa. |
Deshamukhya C, Das BJ, Chetri S, Paul D, Chanda DD, Banerjee T, Bhattacharjee A |
Indian J Med Microbiol |
10.4103/ijmm.IJMM_20_118 |
2020 |
* |
| Genetics |
Comparative genomics of the sequential Pseudomonas aeruginosa isolates obtained from the continuous imipenem stress evolution. |
Lu C, Zhou J, Zhang T, Li C, Chen J, Fan J, Qu L, Su X |
Appl Microbiol Biotechnol |
10.1007/s00253-020-10994-1 |
2020 |
* |
| Pathogenicity |
Effects of Polyethyelene Glycol-Desferrioxamine:Gallium Conjugates on Pseudomonas aeruginosa Outer Membrane Permeability and Vancomycin Potentiation. |
Qiao J, Purro M, Liu Z, Xiong MP |
Mol Pharm |
10.1021/acs.molpharmaceut.0c00820 |
2020 |
* |
| Pathogenicity |
Methylene Blue Is an Effective Disclosing Agent for Identifying Bacterial Biofilms on Orthopaedic Implants. |
Shaw JD, Brodke DS, Williams DL, Ashton NN |
J Bone Joint Surg Am |
10.2106/JBJS.20.00091 |
2020 |
* |
| Pathogenicity |
Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms. |
Miller M, Rogers JC, Badham MA, Cadenas L, Brightwell E, Adams J, Tyler C, Sebahar PR, Haussener TJ, Reddy HRK, Looper RE, Williams DL |
PLoS One |
10.1371/journal.pone.0234832 |
2020 |
* |
| Pathogenicity |
Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies. |
Cavalluzzi MM, Budriesi R, De Salvia MA, Quintieri L, Piarulli M, Milani G, Gualdani R, Micucci M, Corazza I, Rosato A, Viale M, Caputo L, Franchini C, Lentini G |
Pharmacol Rep |
10.1007/s43440-020-00167-2 |
2020 |
* |
| Pathogenicity |
A pharmacodynamic study of a new gel containing an extract of Aloe vera and an extract of oak bark for potential treatment of periodontal diseases. |
A TN, S ZD |
Ceska Slov Farm |
123709 |
2020 |
* |
| Pathogenicity |
Synergistically-acting Enterocin LD3 and Plantaricin LD4 Against Gram-Positive and Gram-Negative Pathogenic Bacteria. |
Sheoran P, Tiwari SK |
Probiotics Antimicrob Proteins |
10.1007/s12602-020-09708-w |
2020 |
* |
| Enzymology |
Effects of dietary fern (Adiantum capillus-veneris) leaves powder on serum and mucus antioxidant defence, immunological responses, antimicrobial activity and growth performance of common carp (Cyprinus carpio) juveniles. |
Hoseinifar SH, Jahazi MA, Mohseni R, Raeisi M, Bayani M, Mazandarani M, Yousefi M, Van Doan H, Torfi Mozanzadeh M |
Fish Shellfish Immunol |
10.1016/j.fsi.2020.09.001 |
2020 |
* |
| Pathogenicity |
Intracellular biosynthesis of PbS quantum dots using Pseudomonas aeruginosa ATCC 27853: evaluation of antibacterial effects and DNA cleavage activities. |
Ocal N, Ceylan A, Duman F |
World J Microbiol Biotechnol |
10.1007/s11274-020-02917-z |
2020 |
* |
| Pathogenicity |
Unravelling the Antibacterial Activity of Terminalia sericea Root Bark through a Metabolomic Approach. |
Anokwuru CP, Tankeu S, van Vuuren S, Viljoen A, Ramaite IDI, Taglialatela-Scafati O, Combrinck S |
Molecules |
10.3390/molecules25163683 |
2020 |
* |
| Pathogenicity |
Laboratory-based study of novel antimicrobial cold spray coatings to combat surface microbial contamination. |
Lucas MDI, Botef I, Reid RG, van Vuuren SF |
Infect Control Hosp Epidemiol |
10.1017/ice.2020.335 |
2020 |
* |
| Phenotype |
Cigarette smoke extract induces the Pseudomonas aeruginosa nfxC drug-resistant phenotype. |
Xu M, Zhang H, Yu N, Dong Y, Wang W, Chen Y, Kang J |
J Infect Chemother |
10.1016/j.jiac.2020.07.013 |
2020 |
* |
| Pathogenicity |
Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis. |
Millar BC, McCaughan J, Rendall JC, Moore JE |
Clin Respir J |
10.1111/crj.13262 |
2020 |
* |
| Biotechnology |
Computational Basis for On-Demand Production of Diversified Therapeutic Phage Cocktails. |
Mageeney CM, Sinha A, Mosesso RA, Medlin DL, Lau BY, Rokes AB, Lane TW, Branda SS, Williams KP |
mSystems |
10.1128/mSystems.00659-20 |
2020 |
* |
| Pathogenicity |
Antimicrobial activity and mechanism of peptide CM4 against Pseudomonas aeruginosa. |
Li JF, Zhang JX, Li G, Xu YY, Lu K, Wang ZG, Liu JP |
Food Funct |
10.1039/d0fo01031f |
2020 |
* |
| Phylogeny |
Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. |
Zhao L, Wang S, Li X, He X, Jian L |
Antimicrob Resist Infect Control |
10.1186/s13756-020-00793-8 |
2020 |
* |
| Pathogenicity |
Application of Phenotype Microarray for Profiling Carbon Sources Utilization between Biofilm and Non-Biofilm of Pseudomonas aeruginosa from Clinical Isolates. |
Ismail NS, Subbiah SK, Taib NM |
Curr Pharm Biotechnol |
10.2174/1389201021666200629145217 |
2020 |
* |
| Pathogenicity |
Antimicrobial and Anti-Inflammatory Activity of Some Lathyrus L. (Fabaceae) Species Growing in Turkey. |
Heydari H, Saltan Iscan G, Eryilmaz M, Bahadir Acikara O, Yilmaz Sarialtin S, Tekin M, Coban T |
Turk J Pharm Sci |
10.4274/tjps.galenos.2018.86719 |
2019 |
* |
| Pathogenicity |
In Vitro Antimicrobial Activity of a New Ophthalmic Solution Containing Hexamidine Diisethionate 0.05% (Keratosept). |
Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S |
Cornea |
10.1097/ICO.0000000000002375 |
2020 |
* |
| Stress |
Heavy metals-resistant bacteria (HM-RB): Potential bioremediators of heavy metals-stressed Spinacia oleracea plant. |
Desoky EM, Merwad AM, Semida WM, Ibrahim SA, El-Saadony MT, Rady MM |
Ecotoxicol Environ Saf |
10.1016/j.ecoenv.2020.110685 |
2020 |
* |
| Pathogenicity |
Photodynamic inactivation mediated by 5-aminolevulinic acid of bacteria in planktonic and biofilm forms. |
Bohm GC, Gandara L, Di Venosa G, Mamone L, Buzzola F, Casas A |
Biochem Pharmacol |
10.1016/j.bcp.2020.114016 |
2020 |
* |
| Phylogeny |
Isolation, Characterization, and Screening of Antimicrobial-Producing Actinomycetes from Soil Samples. |
Sapkota A, Thapa A, Budhathoki A, Sainju M, Shrestha P, Aryal S |
Int J Microbiol |
10.1155/2020/2716584 |
2020 |
* |
| Biotechnology |
Use of hydrocarbons sludge as a substrate for the production of biosurfactants by Pseudomonas aeruginosa ATCC 27853. |
Kezrane I, Harouna BM, Hamadache M, Benkortbi O, Amrane A |
Environ Monit Assess |
10.1007/s10661-020-08269-3 |
2020 |
* |
| Pathogenicity |
Antibacterial and Antibiofilm Activity of Biosynthesized Silver Nanoparticles Coated With Exopolysaccharides Obtained From Rhodotorula mucilaginosa. |
Vazquez-Rodriguez A, Vasto-Anzaldo XG, Leon-Buitimea A, Zarate X, Morones-Ramirez JR |
IEEE Trans Nanobioscience |
10.1109/TNB.2020.2985101 |
2020 |
* |
| Pathogenicity |
Nanoporous iron oxide nanoparticle: hydrothermal fabrication, human serum albumin interaction and potential antibacterial effects. |
Mehrabi M, Ghasemi MF, Rasti B, Falahati M, Mirzaie A, Hasan A |
J Biomol Struct Dyn |
10.1080/07391102.2020.1751296 |
2020 |
* |
| Pathogenicity |
Antibacterial activity of chitosan/collagen membranes containing red propolis extract. |
Loureiro KC, Barbosa TC, Nery M, Chaud MV, da Silva CF, Andrade LN, Correa CB, Jaguer A, Padilha FF, Cardoso JC, Souto E, Severino P |
Pharmazie |
10.1691/ph.2020.9050 |
2020 |
* |
| Pathogenicity |
Design, Synthesis, and Antimicrobial Evaluation of New Annelated Pyrimido[2,1-c][1,2,4]triazolo[3,4-f][1,2,4]triazines. |
El Azab IH, Elkanzi NAA |
Molecules |
10.3390/molecules25061339 |
2020 |
* |
| Enzymology |
Levofloxacin-ceftazidime administration regimens combat Pseudomonas aeruginosa in the hollow-fiber infection model simulating abnormal renal function in critically ill patients. |
Zhao L, Li X, He X, Jian L |
BMC Pharmacol Toxicol |
10.1186/s40360-020-0396-5 |
2020 |
* |
| Pathogenicity |
The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces. |
Yamasaki K, Mizuno Y, Kitamura Y, McCanna DJ, Ngo W, Jones LW |
Cont Lens Anterior Eye |
10.1016/j.clae.2020.02.012 |
2020 |
* |
| Pathogenicity |
Phytochemical analyses and antibacterial activities of Erodium, Euphorbia, Logoecia and Tamarix species. |
Al-Hadid KJ, Al-Karablieh N, Sharab A, Mutlak I |
J Infect Dev Ctries |
10.3855/jidc.11776 |
2019 |
* |
| Pathogenicity |
Antimicrobial activity of Asteraceae species against bacterial pathogens isolated from postmenopausal women. |
Chiavari-Frederico MO, Barbosa LN, Carvalho Dos Santos I, Ratti da Silva G, Fernandes de Castro A, de Campos Bortolucci W, Barboza LN, Campos CFAA, Goncalves JE, Menetrier JV, Jacomassi E, Gazim ZC, Wietzikoski S, Dos Reis Livero FA, Wietzikoski Lovato EC |
PLoS One |
10.1371/journal.pone.0227023 |
2020 |
* |
| Metabolism |
Quorum Sensing Inhibitors against Chromobacterium violaceum CV026 Derived from an Actinomycete Metabolite Library. |
Ohta T, Fukumoto A, Iizaka Y, Kato F, Koyama Y, Anzai Y |
Biol Pharm Bull |
10.1248/bpb.b19-00564 |
2020 |
* |
| Pathogenicity |
Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione). |
Novais JS, Rosandiski AC, de Carvalho CM, de Saules Silva LS, Dos S Velasco de Souza LC, Santana MV, Martins NRC, Castro HC, Ferreira VF, Gonzaga DTG, de Resende GO, de C da Silva F |
Curr Top Med Chem |
10.2174/1568026619666191210160342 |
2020 |
* |
| Pathogenicity |
First detected OXA-50 carbapenem-resistant clinical isolates Pseudomonas aeruginosa from Bulgaria and interplay between the expression of main efflux pumps, OprD and intrinsic AmpC. |
Petrova A, Feodorova Y, Miteva-Katrandzhieva T, Petrov M, Murdjeva M |
J Med Microbiol |
10.1099/jmm.0.001106 |
2019 |
* |
| Pathogenicity |
Antibacterial activities, proposed mode of action and cytotoxicity of leaf extracts from Triumfetta welwitschii against Pseudomonas aeruginosa. |
Mombeshora M, Mukanganyama S |
BMC Complement Altern Med |
10.1186/s12906-019-2713-3 |
2019 |
* |
| Enzymology |
Antimicrobial and antioxidative potential of free and immobilised cellobiose dehydrogenase isolated from wood degrading fungi. |
Sulej J, Osinska-Jaroszuk M, Jaszek M, Graz M, Kutkowska J, Pawlik A, Chudzik A, Bancerz R |
Fungal Biol |
10.1016/j.funbio.2019.09.007 |
2019 |
* |
| Pathogenicity |
In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa. |
Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB |
Vet Dermatol |
10.1111/vde.12803 |
2019 |
* |
| Phylogeny |
GC-IMS headspace analyses allow early recognition of bacterial growth and rapid pathogen differentiation in standard blood cultures. |
Drees C, Vautz W, Liedtke S, Rosin C, Althoff K, Lippmann M, Zimmermann S, Legler TJ, Yildiz D, Perl T, Kunze-Szikszay N |
Appl Microbiol Biotechnol |
10.1007/s00253-019-10181-x |
2019 |
* |
| Metabolism |
Overproduction of lipoxygenase from Pseudomonas aeruginosa in Escherichia coli by auto-induction expression and its application in triphenylmethane dyes degradation. |
Lu J, Zhang C, Leong HY, Show PL, Lu F, Lu Z |
J Biosci Bioeng |
10.1016/j.jbiosc.2019.09.006 |
2019 |
* |
| Pathogenicity |
Antibacterial, Antibiofilm, Antiquorum Sensing, Antimotility, and Antioxidant Activities of Green Fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via Protoparmeliopsis muralis Lichen Aqueous Extract against Multi-Drug-Resistant Bacteria. |
Alavi M, Karimi N, Valadbeigi T |
ACS Biomater Sci Eng |
10.1021/acsbiomaterials.9b00274 |
2019 |
* |
| Pathogenicity |
In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM((R)) ). |
Pinna A, Donadu MG, Usai D, Dore S, D'Amico-Ricci G, Boscia F, Zanetti S |
Acta Ophthalmol |
10.1111/aos.14243 |
2019 |
* |
| Pathogenicity |
Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay. |
Fonseca E Silva D, Silva-Dias A, Gomes R, Martins-Oliveira I, Ramos MH, Rodrigues AG, Canton R, Pina-Vaz C |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2019.08.016 |
2019 |
* |
| Pathogenicity |
Bacterial inhibition efficiency of prilocaine and bupivacaine. |
Kesici S, Demirci M, Kesici U |
Int Wound J |
10.1111/iwj.13180 |
2019 |
* |
| Pathogenicity |
Antibacterial effects of lidocaine and adrenaline. |
Kesici S, Demirci M, Kesici U |
Int Wound J |
10.1111/iwj.13182 |
2019 |
* |
| Pathogenicity |
Synthesis, Characterization and Antimicrobial Activity of Garcinol Capped Silver Nanoparticles. |
Fernando HN, Kumarasinghe KGUR, Gunasekara TDCP, Wijekoon HPSK, Ekanayaka EMAK, Rajapaksha SP, Fernando SSN, Jayaweera PM |
J Microbiol Biotechnol |
10.4014/jmb.1904.04032 |
2019 |
* |
| Pathogenicity |
Evaluating antimicrobial and antioxidant capacity of endemic Phlomis russeliana from Turkey and its antiproliferative effect on Human Caco-2 Cell Lines. |
Alpay M, Dulger G, Sahin IE, Dulger B |
An Acad Bras Cienc |
10.1590/0001-3765201920180404 |
2019 |
* |
| Pathogenicity |
Antimicrobial screening of some selected Turkish medicinal plants. |
Moghaddam NS, Eryilmaz M, Altanlar N, Yildirim O |
Pak J Pharm Sci |
|
2019 |
* |
| Metabolism |
Analysis of a long term starved Pseudomonas aeruginosa ATCC27853 in seawater microcosms. |
Machreki Y, Kouidhi B, Machreki S, Chaieb K, Saenz Y |
Microb Pathog |
10.1016/j.micpath.2019.103595 |
2019 |
* |
| Pathogenicity |
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel beta-Lactamase Inhibitor Enmetazobactam. |
Belley A, Huband MD, Fedler KA, Watters AA, Flamm RK, Shapiro S, Knechtle P |
J Clin Microbiol |
10.1128/JCM.00607-19 |
2019 |
* |
| Phylogeny |
Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions. |
Diaz-Roa A, Espinoza-Culupu A, Torres-Garcia O, Borges MM, Avino IN, Alves FL, Miranda A, Patarroyo MA, da Silva PI Jr, Bello FJ |
Molecules |
10.3390/molecules24112077 |
2019 |
* |
| Pathogenicity |
Antimicrobial effects of local anaesthetics. |
Kesici U, Demirci M, Kesici S |
Int Wound J |
10.1111/iwj.13153 |
2019 |
* |
| Metabolism |
Pseudomonas aeruginosa alkaline protease exhibits a high renaturation capability. |
Andrejko M, Sieminska-Kuczer A, Janczarek M, Janik E, Bednarczyk M, Gagos M, Cytrynska M |
Acta Biochim Pol |
10.18388/abp.2018_2741 |
2019 |
* |
| Pathogenicity |
Novel 5-substituted derivatives of 2'-deoxy-6-azauridine with antibacterial activity. |
Negrya SD, Efremenkova OV, Solyev PN, Chekhov VO, Ivanov MA, Sumarukova IG, Karpenko IL, Kochetkov SN, Alexandrova LA |
J Antibiot (Tokyo) |
10.1038/s41429-019-0158-z |
2019 |
* |
| Metabolism |
Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are affected by sub-lethal photodynamic inactivation. |
Hendiani S, Pornour M, Kashef N |
Photodiagnosis Photodyn Ther |
10.1016/j.pdpdt.2019.02.010 |
2019 |
* |
| Phylogeny |
Bioactive exopolysaccharide from Neopestalotiopsis sp. strain SKE15: Production, characterization and optimization. |
Fooladi T, Soudi MR, Alimadadi N, Savedoroudi P, Heravi MM |
Int J Biol Macromol |
10.1016/j.ijbiomac.2019.01.203 |
2019 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of novel 1,2,3-triazole-conjugates of quinazolin-4-ones. |
Glowacka IE, Grzonkowski P, Lisiecki P, Kalinowski L, Piotrowska DG |
Arch Pharm (Weinheim) |
10.1002/ardp.201800302 |
2019 |
* |
| Pathogenicity |
Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics. |
Nussbaumer-Proll AK, Knotzer S, Eberl S, Reiter B, Stimpfl T, Jager W, Poschner S, Zeitlinger M |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-018-03452-4 |
2019 |
* |
| Phylogeny |
Potential of lactic acid bacteria from Pico cheese for starter culture development. |
Camara SP, Dapkevicius A, Riquelme C, Elias RB, Silva C, Malcata FX, Dapkevicius M |
Food Sci Technol Int |
10.1177/1082013218823129 |
2019 |
* |
| Pathogenicity |
Albumin binding, anticancer and antibacterial properties of synthesized zero valent iron nanoparticles. |
Anbouhi TS, Esfidvajani EM, Nemati F, Haghighat S, Sari S, Attar F, Pakaghideh A, Sohrabi MJ, Mousavi SE, Falahati M |
Int J Nanomedicine |
10.2147/IJN.S188497 |
2018 |
* |
| Metabolism |
Molecular Identification and Antimicrobial Activity of Vaginal Lactobacillus sp. |
Eryilmaz M, Gurpinar SS, Palabiyik IM, Guriz H, Gerceker D |
Curr Pharm Biotechnol |
10.2174/1389201020666190110164123 |
2018 |
* |
| Pathogenicity |
Antimicrobial effect of novel hydrogel matrix based on natural polysaccharide Sterculia urens. |
Lipovy B, Holoubek J, Vacek L, Ruzicka F, Nedomova E, Postulkova H, Vojtova L |
Epidemiol Mikrobiol Imunol |
107027 |
|
* |
| Metabolism |
Novel linear lipopeptide paenipeptin C' binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane. |
Moon SH, Huang E |
BMC Microbiol |
10.1186/s12866-018-1381-7 |
2019 |
* |
| Pathogenicity |
Sub-lethal antimicrobial photodynamic inactivation: an in vitro study on quorum sensing-controlled gene expression of Pseudomonas aeruginosa biofilm formation. |
Hendiani S, Pornour M, Kashef N |
Lasers Med Sci |
10.1007/s10103-018-02707-y |
2019 |
* |
| Pathogenicity |
Isothiazolopyridine Mannich bases and their antibacterial effect. |
Swiatek P, Strzelecka M |
Adv Clin Exp Med |
10.17219/acem/99310 |
2019 |
* |
| Pathogenicity |
Potential Properties of Lactobacillus plantarum F-10 as a Bio-control Strategy for Wound Infections. |
Onbas T, Osmanagaoglu O, Kiran F |
Probiotics Antimicrob Proteins |
10.1007/s12602-018-9486-8 |
2019 |
* |
| Phylogeny |
Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megaterium strain isolated from oral microflora. |
Al-Thubiani ASA, Maher YA, Fathi A, Abourehab MAS, Alarjah M, Khan MSA, Al-Ghamdi SB |
Saudi Pharm J |
10.1016/j.jsps.2018.05.019 |
2018 |
* |
| Enzymology |
Phytochemical analysis and antimicrobial activity of aqueous and methanolic extracts of the flowers of Nelumbium speciosum. |
Bashir S, Sial RN, Ashraf MU, Mushtaq MN, Adnan MA, Erum A |
Pak J Pharm Sci |
|
2018 |
* |
| Pathogenicity |
Iodine-supported titanium implants have good antimicrobial attachment effects. |
Inoue D, Kabata T, Kajino Y, Shirai T, Tsuchiya H |
J Orthop Sci |
10.1016/j.jos.2018.10.010 |
2018 |
* |
| Cultivation |
Influence of Laboratory Culture Media on in vitro Growth, Adhesion, and Biofilm Formation of Pseudomonas aeruginosa and Staphylococcus aureus. |
Wijesinghe G, Dilhari A, Gayani B, Kottegoda N, Samaranayake L, Weerasekera M |
Med Princ Pract |
10.1159/000494757 |
2018 |
* |
| Pathogenicity |
Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens. |
Condo C, Anacarso I, Sabia C, Iseppi R, Anfelli I, Forti L, de Niederhausern S, Bondi M, Messi P |
Nat Prod Res |
10.1080/14786419.2018.1490904 |
2018 |
* |
| Pathogenicity |
In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation. |
Musumeci R, Bandello F, Martinelli M, Calaresu E, Cocuzza CE |
Eur J Ophthalmol |
10.1177/1120672118802541 |
2018 |
* |
| Biotechnology |
Botryococcus braunii as a bioreactor for the production of nanoparticles with antimicrobial potentialities. |
Arevalo-Gallegos A, Garcia-Perez JS, Carrillo-Nieves D, Ramirez-Mendoza RA, Iqbal HM, Parra-Saldivar R |
Int J Nanomedicine |
10.2147/IJN.S174205 |
2018 |
* |
| Pathogenicity |
Potential bactericidal activity of S. nux-vomica-ZnO nanocomposite against multidrug-resistant bacterial pathogens and wound-healing properties. |
Steffy K, Shanthi G, Maroky AS, Selvakumar S |
J Trace Elem Med Biol |
10.1016/j.jtemb.2018.07.009 |
2018 |
* |
| Pathogenicity |
Formulation Optimization of Chitosan-Stabilized Silver Nanoparticles Using In Vitro Antimicrobial Assay. |
Pansara C, Chan WY, Parikh A, Trott DJ, Mehta T, Mishra R, Garg S |
J Pharm Sci |
10.1016/j.xphs.2018.09.011 |
2018 |
* |
| Cultivation |
Soup with or without meatballs: Impact of nutritional factors on the MIC, kill-rates and growth-rates. |
Mouton JW |
Eur J Pharm Sci |
10.1016/j.ejps.2018.09.008 |
2018 |
* |
| Enzymology |
Stability and low induction propensity of cefiderocol against chromosomal AmpC beta-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae. |
Ito A, Nishikawa T, Ota M, Ito-Horiyama T, Ishibashi N, Sato T, Tsuji M, Yamano Y |
J Antimicrob Chemother |
10.1093/jac/dky317 |
2018 |
* |
| Pathogenicity |
Antibacterial activity of traditional spices against lower respiratory tract pathogens: combinatorial effects of Trachyspermum ammi essential oil with conventional antibiotics. |
Gradinaru AC, Trifan A, Spac A, Brebu M, Miron A, Aprotosoaie AC |
Lett Appl Microbiol |
10.1111/lam.13069 |
2018 |
* |
| Biotechnology |
Simplistic approach in extracellular synthesis of silver nanoparticles via bioreducing potential of Planococcus plakortidis strain BGCC-51 isolated from dye industry effluent soil. |
Chokriwal A, Stephen BJ, Jain D, Singh A |
IET Nanobiotechnol |
10.1049/iet-nbt.2017.0251 |
2018 |
* |
| Pathogenicity |
Antiplanktonic, antibiofilm, antiswarming motility and antiquorum sensing activities of green synthesized Ag-TiO2, TiO2-Ag, Ag-Cu and Cu-Ag nanocomposites against multi-drug-resistant bacteria. |
Alavi M, Karimi N |
Artif Cells Nanomed Biotechnol |
10.1080/21691401.2018.1496923 |
2018 |
* |
| Pathogenicity |
Synthesis and characterization of ZnO phytonanocomposite using Strychnos nux-vomica L. (Loganiaceae) and antimicrobial activity against multidrug-resistant bacterial strains from diabetic foot ulcer. |
Steffy K, Shanthi G, Maroky AS, Selvakumar S |
J Adv Res |
10.1016/j.jare.2017.11.001 |
2017 |
* |
| Pathogenicity |
Titanium oxide nanoparticles fabrication, hemoglobin interaction, white blood cells cytotoxicity, and antibacterial studies. |
Abdolmajid E, Kharazi H, Chalaki M, Khojasteh M, Haghighat S, Attar F, Nemati F, Falahati M |
J Biomol Struct Dyn |
10.1080/07391102.2018.1499555 |
2018 |
* |
| Pathogenicity |
Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates. |
Bouzina A, Bechlem K, Berredjem H, Belhani B, Becheker I, Lebreton J, Le Borgne M, Bouaziz Z, Marminon C, Berredjem M |
Molecules |
10.3390/molecules23071682 |
2018 |
* |
| Pathogenicity |
Comparison of antimicrobial activity of selected, commercially available wound dressing materials. |
Szweda P, Gorczyca G, Tylingo R |
J Wound Care |
10.12968/jowc.2018.27.5.320 |
2018 |
* |
| Pathogenicity |
Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 mug. |
Koeth LM, Matuschek E, Kahlmeter G, Stone G |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-018-3215-9 |
2018 |
* |
| Pathogenicity |
Antimicrobial Potential of Sicilian Honeys Against Staphylococcus aureus and Pseudomonas aeruginosa. |
Coniglio MA, Lagana P, Faro G, Marranzano M |
J AOAC Int |
10.5740/jaoacint.17-0450 |
2018 |
* |
| Pathogenicity |
Photodynamic inactivation of foodborne bacteria by eosin Y. |
Bonin E, Dos Santos AR, Fiori da Silva A, Ribeiro LH, Favero ME, Campanerut-Sa PAZ, de Freitas CF, Caetano W, Hioka N, Mikcha JMG |
J Appl Microbiol |
10.1111/jam.13727 |
2018 |
* |
| Pathogenicity |
Membrane-acting bacteriocin purified from a soil isolate Pediococcus pentosaceus LB44 shows broad host-range. |
Kaur R, Tiwari SK |
Biochem Biophys Res Commun |
10.1016/j.bbrc.2018.03.062 |
2018 |
* |
| Phylogeny |
Safety characterisation and inhibition of fungi and bacteria by a novel multiple enterocin-producing Enterococcus lactis 4CP3 strain. |
Ben Braiek O, Cremonesi P, Morandi S, Smaoui S, Hani K, Ghrairi T |
Microb Pathog |
10.1016/j.micpath.2018.03.005 |
2018 |
* |
| Phylogeny |
Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation. |
Le Roes-Hill M, Durrell K, Prins A, Meyers PR |
J Antibiot (Tokyo) |
10.1038/s41429-018-0036-0 |
2018 |
* |
| Pathogenicity |
Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model. |
Bilal H, Peleg AY, McIntosh MP, Styles IK, Hirsch EB, Landersdorfer CB, Bergen PJ |
J Antimicrob Chemother |
10.1093/jac/dky045 |
2018 |
* |
| Genetics |
Single-Nucleotide Polymorphism Genotyping of exoS in Pseudomonas aeruginosa Using Dual-Color Fluorescence Hybridization and Magnetic Separation. |
Tang Y, Ali Z, Dai J, Liu X, Wu Y, Chen Z, He N, Li S, Wang L |
J Biomed Nanotechnol |
10.1166/jbn.2018.2525 |
2018 |
* |
| Pathogenicity |
From bugs to drugs: Combating antimicrobial resistance by discovering novel antibiotics. |
Abou Fayad A, Itani D, Miari M, Tanelian A, Iweir S, Matar GM |
J Infect Dev Ctries |
10.3855/jidc.10108 |
2018 |
* |
| Pathogenicity |
Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa. |
Holfeld L, Knappe D, Hoffmann R |
J Antimicrob Chemother |
10.1093/jac/dkx482 |
2018 |
* |
| Metabolism |
Biosynthesis and structural characterization of polyhydroxyalkanoates produced by Pseudomonas aeruginosa ATCC 27853 from long odd-chain fatty acids. |
Impallomeni G, Ballistreri A, Carnemolla GM, Rizzo MG, Nicolo MS, Guglielmino SPP |
Int J Biol Macromol |
10.1016/j.ijbiomac.2017.12.037 |
2017 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of amino acid and peptide derivatives of mycophenolic acid. |
Siebert A, Wysocka M, Krawczyk B, Cholewinski G, Rachon J |
Eur J Med Chem |
10.1016/j.ejmech.2017.11.094 |
2017 |
* |
| Pathogenicity |
Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against Enterococcus faecalis Clinical Isolates and Reference Strains. |
Kart D, Kustimur AS, Sagiroglu M, Kalkanci A |
Balkan Med J |
10.4274/balkanmedj.2016.1853 |
2017 |
* |
| Pathogenicity |
Bacterial resistance to silver nanoparticles and how to overcome it. |
Panacek A, Kvitek L, Smekalova M, Vecerova R, Kolar M, Roderova M, Dycka F, Sebela M, Prucek R, Tomanec O, Zboril R |
Nat Nanotechnol |
10.1038/s41565-017-0013-y |
2017 |
* |
| Pathogenicity |
Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin. |
Turlej-Rogacka A, Xavier BB, Janssens L, Lammens C, Zarkotou O, Pournaras S, Goossens H, Malhotra-Kumar S |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-017-3140-3 |
2017 |
* |
| Pathogenicity |
In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis. |
Hon KL, Ip M, Wong CK, Chan BCL, Leung PC, Leung TF |
J Dermatolog Treat |
10.1080/09546634.2017.1395804 |
2017 |
* |
| Pathogenicity |
Antibacterial and antifungal activities of pyroligneous acid from wood of Eucalyptus urograndis and Mimosa tenuiflora. |
de Souza Araujo E, Pimenta AS, Feijo FMC, Castro RVO, Fasciotti M, Monteiro TVC, de Lima KMG |
J Appl Microbiol |
10.1111/jam.13626 |
2017 |
* |
| Pathogenicity |
Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. |
Diez-Aguilar M, Morosini MI, Koksal E, Oliver A, Ekkelenkamp M, Canton R |
Antimicrob Agents Chemother |
10.1128/AAC.01650-17 |
2017 |
* |
| Pathogenicity |
Green synthesis, biological and spectroscopic study on the interaction of multi-component Mannich bases of imidazo[2,1-b]benzothiazoles with human serum albumin. |
Maddili SK, Yandrati LP, Siddam S, Kannekanti VK, Gandham H |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2017.08.026 |
2017 |
* |
| Pathogenicity |
Pseudomonas aeruginosa Trent and zinc homeostasis. |
Davies CB, Harrison MD, Huygens F |
FEMS Microbiol Lett |
10.1093/femsle/fnx151 |
2017 |
* |
| Pathogenicity |
Lipophilic gold(I) complexes with 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione moieties: synthesis and their cytotoxic and antimicrobial activities. |
de Almeida AM, de Oliveira BA, de Castro PP, de Mendonca CC, Furtado RA, Nicolella HD, da Silva VL, Diniz CG, Tavares DC, Silva H, de Almeida MV |
Biometals |
10.1007/s10534-017-0046-6 |
2017 |
* |
| Pathogenicity |
Biosynthesized silver nanoparticles: are they effective antimicrobials? |
Peiris MK, Gunasekara CP, Jayaweera PM, Arachchi ND, Fernando N |
Mem Inst Oswaldo Cruz |
10.1590/0074-02760170023 |
2017 |
* |
| Pathogenicity |
Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus. |
Mombeshora M, Mukanganyama S |
BMC Res Notes |
10.1186/s13104-017-2637-2 |
2017 |
* |
| Metabolism |
Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo. |
Li Y, Huang J, Li L, Liu L |
Cell Physiol Biochem |
10.1159/000479411 |
2017 |
* |
| Pathogenicity |
Antimicrobial Activity of Selected Polyphenols and Capsaicinoids Identified in Pepper (Capsicum annuum L.) and Their Possible Mode of Interaction. |
Mokhtar M, Ginestra G, Youcefi F, Filocamo A, Bisignano C, Riazi A |
Curr Microbiol |
10.1007/s00284-017-1310-2 |
2017 |
* |
| Metabolism |
[Effects of Na(+) /H(+) exchanger 1 inhibitor on intestinal injury of rats with burn sepsis and the mechanism]. |
Li WP, Zhao GY, Yang XK |
Zhonghua Shao Shang Za Zhi |
10.3760/cma.j.issn.1009-2587.2017.06.013 |
2017 |
* |
| Phylogeny |
Comparative genome and transcriptome analysis reveals distinctive surface characteristics and unique physiological potentials of Pseudomonas aeruginosa ATCC 27853. |
Cao H, Lai Y, Bougouffa S, Xu Z, Yan A |
BMC Genomics |
10.1186/s12864-017-3842-z |
2017 |
* |
| Pathogenicity |
Effect of Supercritical Carbon Dioxide Extraction Parameters on the Biological Activities and Metabolites Present in Extracts from Arthrospira platensis. |
Esquivel-Hernandez DA, Rodriguez-Rodriguez J, Cuellar-Bermudez SP, Garcia-Perez JS, Mancera-Andrade EI, Nunez-Echevarria JE, Ontiveros-Valencia A, Rostro-Alanis M, Garcia-Garcia RM, Torres JA, Chen WN, Parra-Saldivar R |
Mar Drugs |
10.3390/md15060174 |
2017 |
* |
| Pathogenicity |
Adsorption and photocatalysis efficiency of magnetite quantum dots anchored tin dioxide nanofibers for removal of mutagenic compound: Toxicity evaluation and antibacterial activity. |
Fakhri A, Naji M, Nejad PA |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2017.05.041 |
2017 |
* |
| Pathogenicity |
Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures. |
Miller N, Brassinne L, Allemeersch D |
Acta Clin Belg |
10.1080/17843286.2017.1331618 |
2017 |
* |
| Pathogenicity |
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model. |
Lin YW, Zhou Q, Onufrak NJ, Wirth V, Chen K, Wang J, Forrest A, Chan HK, Li J |
Antimicrob Agents Chemother |
10.1128/AAC.00211-17 |
2017 |
* |
| Pathogenicity |
Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N-acetyl cysteine. |
Hamed S, Emara M, Shawky RM, El-Domany RA, Youssef T |
J Basic Microbiol |
10.1002/jobm.201700087 |
2017 |
* |
| Pathogenicity |
Effect of GNP functionalisation and multiple N-methylation of beta-amyloid residue (32-37) on Gram-positive bacterium. |
Hemmaragala NM, Abrahamse H, George BP |
IET Nanobiotechnol |
10.1049/iet-nbt.2016.0083 |
2017 |
* |
| Pathogenicity |
Ultraviolet/ultrasound-activated persulfate for degradation of drug by zinc selenide quantum dots: Catalysis and microbiology study. |
Fakhri A, Naji M, Tahami S |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2017.04.024 |
2017 |
* |
| Pathogenicity |
Self assembled snowball-like hybrid nanostructures comprising Viburnum opulus L. extract and metal ions for antimicrobial and catalytic applications. |
Ildiz N, Baldemir A, Altinkaynak C, Ozdemir N, Yilmaz V, Ocsoy I |
Enzyme Microb Technol |
10.1016/j.enzmictec.2017.04.003 |
2017 |
* |
| Pathogenicity |
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design. |
Huband MD, Ito A, Tsuji M, Sader HS, Fedler KA, Flamm RK |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2017.03.011 |
2017 |
* |
| Metabolism |
Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. |
Greifova G, Majekova H, Greif G, Body P, Greifova M, Dubnickova M |
Folia Microbiol (Praha) |
10.1007/s12223-017-0524-9 |
2017 |
* |
| Metabolism |
Stigmatellin Y - An anti-biofilm compound from Bacillus subtilis BR4 possibly interferes in PQS-PqsR mediated quorum sensing system in Pseudomonas aeruginosa. |
Boopathi S, Vashisth R, Manoharan P, Kandasamy R, Sivakumar N |
Bioorg Med Chem Lett |
10.1016/j.bmcl.2017.03.074 |
2017 |
* |
| Metabolism |
Fermentation of sarshir (kaymak) by lactic acid bacteria: antibacterial activity, antioxidant properties, lipid and protein oxidation and fatty acid profile. |
Hashemi SMB, Mousavi Khaneghah A, Kontominas MG, Es I, Sant'Ana AS, Martinez RR, Drider D |
J Sci Food Agric |
10.1002/jsfa.8329 |
2017 |
* |
| Pathogenicity |
Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates. |
Cabassi CS, Sala A, Santospirito D, Alborali GL, Carretto E, Ghibaudo G, Taddei S |
Ann Clin Microbiol Antimicrob |
10.1186/s12941-017-0193-1 |
2017 |
* |
| Pathogenicity |
Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities. |
Abdissa D, Geleta G, Bacha K, Abdissa N |
PLoS One |
10.1371/journal.pone.0173882 |
2017 |
* |
| Pathogenicity |
Bacterial and fungal biofilm formation on contact lenses and their susceptibility to lens care solutions. |
Kackar S, Suman E, Kotian MS |
Indian J Med Microbiol |
10.4103/ijmm.IJMM_16_273 |
2017 |
* |
| Pathogenicity |
Evaluation of phytochemicals from medicinal plants of Myrtaceae family on virulence factor production by Pseudomonas aeruginosa. |
Musthafa KS, Sianglum W, Saising J, Lethongkam S, Voravuthikunchai SP |
APMIS |
10.1111/apm.12672 |
2017 |
* |
| Pathogenicity |
In vitro cytotoxicity and antimicrobial activity of Talaromyces flavus SP5 inhabited in the marine sediment of Southern Coast of India. |
Anand BG, Thomas CK, Prakash S |
Chin J Nat Med |
10.1016/S1875-5364(17)30016-X |
2016 |
* |
| Pathogenicity |
Poly(carboxylic acid)-Cyclodextrin/Anionic Porphyrin Finished Fabrics as Photosensitizer Releasers for Antimicrobial Photodynamic Therapy. |
Castriciano MA, Zagami R, Casaletto MP, Martel B, Trapani M, Romeo A, Villari V, Sciortino MT, Grasso L, Guglielmino S, Scolaro LM, Mazzaglia A |
Biomacromolecules |
10.1021/acs.biomac.6b01752 |
2017 |
* |
| Pathogenicity |
Antimicrobial activity of chemically modified dextran derivatives. |
Tuchilus CG, Nichifor M, Mocanu G, Stanciu MC |
Carbohydr Polym |
10.1016/j.carbpol.2017.01.006 |
2017 |
* |
| Pathogenicity |
A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria. |
Zhu C, Schneider EK, Wang J, Kempe K, Wilson P, Velkov T, Li J, Davis TP, Whittaker MR, Haddleton DM |
J Control Release |
10.1016/j.jconrel.2017.02.005 |
2017 |
* |
| Pathogenicity |
The Essential Oils of Rhaponticum carthamoides Hairy Roots and Roots of Soil-Grown Plants: Chemical Composition and Antimicrobial, Anti-Inflammatory, and Antioxidant Activities. |
Skala E, Rijo P, Garcia C, Sitarek P, Kalemba D, Toma M, Szemraj J, Pytel D, Wysokinska H, Sliwinski T |
Oxid Med Cell Longev |
10.1155/2016/8505384 |
2016 |
* |
| Phylogeny |
ANTIBACTERIAL PROPERTY TESTING OF TWO SPECIES OF TROPICAL PLANT LASIANTHUS (RUBIACEAE). |
Napiroon T, Balslev H, Duangjai S, Sookchaloem D, Chayamarit K, Santimaleeworagun W, Vajrodaya S |
Southeast Asian J Trop Med Public Health |
|
2017 |
* |
| Pathogenicity |
Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model. |
Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, Chan HK, Li J |
Antimicrob Agents Chemother |
10.1128/AAC.02025-16 |
2017 |
* |
| Enzymology |
The Effect of Pelargonium endlicherianum Fenzl. root extracts on formation of nanoparticles and their antimicrobial activities. |
Seker Karatoprak G, Aydin G, Altinsoy B, Altinkaynak C, Kosar M, Ocsoy I |
Enzyme Microb Technol |
10.1016/j.enzmictec.2016.10.019 |
2016 |
* |
| Pathogenicity |
Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds. |
Moreira CS, Silva AC, Novais JS, Sa Figueiredo AM, Ferreira VF, da Rocha DR, Castro HC |
J Appl Microbiol |
10.1111/jam.13369 |
2017 |
* |
| Pathogenicity |
Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study. |
Pan AJ, Mei Q, Ye Y, Li HR, Liu B, Li JB |
J Antibiot (Tokyo) |
10.1038/ja.2016.124 |
2016 |
* |
| Pathogenicity |
The comparison of antimicrobial effectiveness of contact lens solutions. |
Kal A, Toker MI, Kaya S |
Int Ophthalmol |
10.1007/s10792-016-0375-4 |
2016 |
* |
| Metabolism |
Phosphatidylcholine affects the secretion of the alkaline phosphatase PhoA in Pseudomonas strains. |
Liu X, Long D, You H, Yang D, Zhou S, Zhang S, Li M, He M, Xiong M, Wang X |
Microbiol Res |
10.1016/j.micres.2016.02.001 |
2016 |
* |
| Pathogenicity |
Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii. |
Silva Santos K, Barbosa AM, Pereira da Costa L, Pinheiro MS, Oliveira MB, Ferreira Padilha F |
Molecules |
10.3390/molecules21091255 |
2016 |
* |
| Pathogenicity |
[In vitro antibacterial activity of Curcuma longa (Zingiberaceae) against nosocomial bacteria in Monteria, Colombia]. |
Mendez Alvarez N, Angulo Ortiz A, Contreras Martinez O |
Rev Biol Trop |
|
2016 |
* |
| Pathogenicity |
New Adamantyl Chalcones: Synthesis, Antimicrobial and Anticancer Activities. |
Tabbi A, Tebbani D, Caporale A, Saturnino C, Nabavi SF, Giuseppe P, Arra C, Canturk Z, Turan-Zitouni G, Merazig H, Sobarzo-Sanchez E, Rastrelli L |
Curr Top Med Chem |
10.2174/1568026616666160824121935 |
2017 |
* |
| Pathogenicity |
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa. |
Rees VE, Bulitta JB, Oliver A, Tsuji BT, Rayner CR, Nation RL, Landersdorfer CB |
J Antimicrob Chemother |
10.1093/jac/dkw297 |
2016 |
* |
| Metabolism |
Biomimetic synthesis of selenium nanoparticles by Pseudomonas aeruginosa ATCC 27853: An approach for conversion of selenite. |
Kora AJ, Rastogi L |
J Environ Manage |
10.1016/j.jenvman.2016.06.029 |
2016 |
* |
| Pathogenicity |
Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro. |
Aldahoun MA, Jaafar MS, Al-Akhras MH, Bououdina M |
Artif Cells Nanomed Biotechnol |
10.1080/21691401.2016.1178137 |
2016 |
* |
| Pathogenicity |
Antibacterial and Antibiofilm Effects of Boron on Different Bacteria. |
Sayin Z, Ucan US, Sakmanoglu A |
Biol Trace Elem Res |
10.1007/s12011-016-0637-z |
2016 |
* |
| Enzymology |
Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model. |
Mohamed AF, Kristoffersson AN, Karvanen M, Nielsen EI, Cars O, Friberg LE |
J Antimicrob Chemother |
10.1093/jac/dkv488 |
2016 |
* |
| Metabolism |
[Identification and bactericidal activity of a novel Cathelicidin family member from skin of Bufu bufo gargarizans]. |
Zhan B, Gao YY, Lin WP, Jia GT, Sun TY, Lee WH |
Zhongguo Zhong Yao Za Zhi |
10.4268/cjcmm20160414 |
2016 |
* |
| Pathogenicity |
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. |
Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H |
Molecules |
10.3390/molecules21010062 |
2016 |
* |
| Pathogenicity |
Medicinal Plants Used by a Mbya-Guarani Tribe Against Infections: Activity on KPC-Producing Isolates and Biofilm-Forming Bacteria. |
Brandelli CL, Ribeiro VB, Zimmer KR, Barth AL, Tasca T, Macedo AJ |
Nat Prod Commun |
|
2015 |
* |
| Pathogenicity |
Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. |
Adahoun MA, Al-Akhras MH, Jaafar MS, Bououdina M |
Artif Cells Nanomed Biotechnol |
10.3109/21691401.2015.1129628 |
2016 |
* |
| Pathogenicity |
Antimicrobial activity of some Alnus species. |
Altinyay C, Eryilmaz M, Yazgan AN, Sever Yilmaz B, Altun ML |
Eur Rev Med Pharmacol Sci |
|
2015 |
* |
| Pathogenicity |
Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections. |
Affhan S, Dachang W, Xin Y, Shang D |
Genet Mol Res |
10.4238/2015.December.16.5 |
2015 |
* |
| Pathogenicity |
SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW SULFONAMIDE ISOXAZOLO[5,4-b]PYRIDINE DERIVATIVES. |
Poreba K, Pawlik K, Rembacz KP, Kurowska E, Matuszyk J, Dlugosz A |
Acta Pol Pharm |
|
2015 |
* |
| Enzymology |
In vitro comparison of epidural bacteria filters permeability and screening scanning electron microscopy. |
Sener A, Erkin Y, Sener A, Tasdogen A, Dokumaci E, Elar Z |
Braz J Anesthesiol |
10.1016/j.bjane.2013.08.004 |
2013 |
* |
| Biotechnology |
Antimicrobial activity of silver doped fabrics for the production of hospital uniforms. |
Condo C, Messi P, Anacarso I, Sabia C, Iseppi R, Bondi M, de Niederhausern S |
New Microbiol |
496M817 |
2015 |
* |
| Genetics |
Draft Genome Sequences of Nine Pseudomonas aeruginosa Strains, Including Eight Clinical Isolates. |
Jeraldo P, Cunningham SA, Quest D, Sikkink RA, O'Brien D, Eckloff BW, Patel R, Chia N |
Genome Announc |
10.1128/genomeA.01154-15 |
2015 |
* |
| Pathogenicity |
Glucocorticoids can affect Pseudomonas aeruginosa (ATCC 27853) internalization and intracellular calcium concentration in cystic fibrosis bronchial epithelial cells. |
Hussain R, Shahror R, Karpati F, Roomans GM |
Exp Lung Res |
10.3109/01902148.2015.1046199 |
2015 |
* |
| Metabolism |
Extracellular matrix-associated proteins form an integral and dynamic system during Pseudomonas aeruginosa biofilm development. |
Zhang W, Sun J, Ding W, Lin J, Tian R, Lu L, Liu X, Shen X, Qian PY |
Front Cell Infect Microbiol |
10.3389/fcimb.2015.00040 |
2015 |
* |
| Pathogenicity |
Antimicrobial activity and chemical composition of the essential oils of Portuguese Foeniculum vulgare fruits. |
Mota AS, Martins MR, Arantes S, Lopes VR, Bettencourt E, Pombal S, Gomes AC, Silva LA |
Nat Prod Commun |
|
2015 |
* |
| Pathogenicity |
Photodynamic Inactivation Mediated by Erythrosine and its Derivatives on Foodborne Pathogens and Spoilage Bacteria. |
Yassunaka NN, Freitas CF, Rabello BR, Santos PR, Caetano W, Hioka N, Nakamura TU, Abreu Filho BA, Graton Mikcha JM |
Curr Microbiol |
10.1007/s00284-015-0827-5 |
2015 |
* |
| Pathogenicity |
Polarized currents inhibit in vitro growth of bacteria colonizing cutaneous ulcers. |
Gomes RC, Brandino HE, de Sousa NT, Santos MF, Martinez R, Guirro RR |
Wound Repair Regen |
10.1111/wrr.12296 |
2015 |
* |
| Pathogenicity |
Multifunctional lanthanide and silver ion co-doped nano-chlorapatites with combined spectroscopic and antimicrobial properties. |
Wiglusz RJ, Drulis-Kawa Z, Pazik R, Zawisza K, Dorotkiewicz-Jach A, Roszkowiak J, Nedelec JM |
Dalton Trans |
10.1039/c5dt00046g |
2015 |
* |
| Metabolism |
Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors. |
Wang Y, Yan M, Ma R, Ma S |
Arch Pharm (Weinheim) |
10.1002/ardp.201400412 |
2015 |
* |
| Pathogenicity |
Design, synthesis and in vitro bactericidal/fungicidal screening of some vanadyl(IV)complexes with mono- and di-substituted ONS donor triazoles. |
Sumrra SH, Hanif M, Chohan ZH |
J Enzyme Inhib Med Chem |
10.3109/14756366.2014.976565 |
2015 |
* |
| Pathogenicity |
Antimicrobial activity of natural products from the flora of Northern Ontario, Canada. |
Vandal J, Abou-Zaid MM, Ferroni G, Leduc LG |
Pharm Biol |
10.3109/13880209.2014.942867 |
2015 |
* |
| Pathogenicity |
Compounds from Geijera parviflora with prostaglandin E2 inhibitory activity may explain its traditional use for pain relief. |
Banbury LK, Shou Q, Renshaw DE, Lambley EH, Griesser HJ, Mon H, Wohlmuth H |
J Ethnopharmacol |
10.1016/j.jep.2015.01.033 |
2015 |
* |
| Pathogenicity |
Anti-virulence potential of eugenyl acetate against pathogenic bacteria of medical importance. |
Musthafa KS, Voravuthikunchai SP |
Antonie Van Leeuwenhoek |
10.1007/s10482-014-0364-4 |
2015 |
* |
| Pathogenicity |
[Influence of Chlorhexidine and Prontosan on Dual Species and Monospecies Biofilms Formed by Staphylococcus aureus and Pseudomonas aeruginosa]. |
Kuznetsova MV, Encheva YA, Samartsev VA |
Antibiot Khimioter |
|
2015 |
* |
| Pathogenicity |
Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia. |
Birkun AA, Kubyshkin AV, Novikov NY, Krivorutchenko YL, Fedosov MI, Postnikova ON, Snitser AA |
J Aerosol Med Pulm Drug Deliv |
10.1089/jamp.2014.1161 |
2014 |
* |
| Pathogenicity |
Development of a novel resin with antimicrobial properties for dental application. |
Castro DT, Holtz RD, Alves OL, Watanabe E, Valente ML, Silva CH, Reis AC |
J Appl Oral Sci |
10.1590/1678-775720130539 |
2014 |
* |
| Pathogenicity |
Anti-adherence potential of Enterococcus durans cells and its cell-free supernatant on plastic and stainless steel against foodborne pathogens. |
Amel AM, Farida B, Djamila S |
Folia Microbiol (Praha) |
10.1007/s12223-014-0367-6 |
2014 |
* |
| Pathogenicity |
Antibacterial and EGFR-tyrosine kinase inhibitory activities of polyhydroxylated xanthones from Garcinia succifolia. |
Duangsrisai S, Choowongkomon K, Bessa LJ, Costa PM, Amat N, Kijjoa A |
Molecules |
10.3390/molecules191219923 |
2014 |
* |
| Pathogenicity |
Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa. |
Rees VE, Bulitta JB, Nation RL, Tsuji BT, Sorgel F, Landersdorfer CB |
J Antimicrob Chemother |
10.1093/jac/dku437 |
2014 |
* |
| Pathogenicity |
Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. |
Dosler S, Karaaslan E |
Peptides |
10.1016/j.peptides.2014.09.021 |
2014 |
* |
| Pathogenicity |
Phloroglucinols from anti-microbial deposit-resins of Australian stingless bees (Tetragonula carbonaria). |
Massaro CF, Smyth TJ, Smyth WF, Heard T, Leonhardt SD, Katouli M, Wallace HM, Brooks P |
Phytother Res |
10.1002/ptr.5225 |
2014 |
* |
| Pathogenicity |
Antibacterial and anti-inflammatory activities of extract and fractions from Pyrrosia petiolosa (Christ et Bar.) Ching. |
Cheng D, Zhang Y, Gao D, Zhang H |
J Ethnopharmacol |
10.1016/j.jep.2014.07.029 |
2014 |
* |
| Pathogenicity |
Photodynamic inactivation of bacteria and viruses using two monosubstituted zinc(II) phthalocyanines. |
Ke MR, Eastel JM, Ngai KL, Cheung YY, Chan PK, Hui M, Ng DK, Lo PC |
Eur J Med Chem |
10.1016/j.ejmech.2014.07.022 |
2014 |
* |
| Pathogenicity |
Oligolysine-conjugated zinc(II) phthalocyanines as efficient photosensitizers for antimicrobial photodynamic therapy. |
Ke MR, Eastel JM, Ngai KL, Cheung YY, Chan PK, Hui M, Ng DK, Lo PC |
Chem Asian J |
10.1002/asia.201402025 |
2014 |
* |
| Pathogenicity |
In vitro evaluation of antimicrobial features of sugammadex. |
Hanci V, Vural A, Hanci SY, Ali Kiraz H, Omur D, Unver A |
Braz J Anesthesiol |
10.1016/j.bjane.2013.09.003 |
2013 |
* |
| Enzymology |
Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model. |
Drusano GL, Liu W, Fikes S, Cirz R, Robbins N, Kurhanewicz S, Rodriquez J, Brown D, Baluya D, Louie A |
J Infect Dis |
10.1093/infdis/jiu237 |
2014 |
* |
| Enzymology |
Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae). |
Massaro CF, Katouli M, Grkovic T, Vu H, Quinn RJ, Heard TA, Carvalho C, Manley-Harris M, Wallace HM, Brooks P |
Fitoterapia |
10.1016/j.fitote.2014.03.024 |
2014 |
* |
| Genetics |
Genome Sequence of Pseudomonas aeruginosa Strain LCT-PA220, Which Was Selected after Space Flight by Using Biolog's Powerful Carbon Source Utilization Technology. |
Xu G, Hu J, Fang X, Zhang X, Wang J, Guo Y, Li T, Chen Z, Dai W, Liu C |
Genome Announc |
10.1128/genomeA.00169-14 |
2014 |
* |
| Phylogeny |
Antibacterial substances from marine algae isolated from Jeddah coast of Red sea, Saudi Arabia. |
Al-Saif SS, Abdel-Raouf N, El-Wazanani HA, Aref IA |
Saudi J Biol Sci |
10.1016/j.sjbs.2013.06.001 |
2013 |
* |
| Pathogenicity |
Antibacterial activity of thioetherhydroxyethylsulfonamide derivatives. |
Vellasco WT Jr, Guedes GP, Facchinetti V, Vasconcelos TR, Vaz MG, Cunico W, de Souza MV, de Paula GR, Fleming ME, Gomes CR |
Med Chem |
10.2174/1573406410666140218103022 |
2014 |
* |
| Metabolism |
Diverse effects of Galleria mellonella infection with entomopathogenic and clinical strains of Pseudomonas aeruginosa. |
Andrejko M, Zdybicka-Barabas A, Cytrynska M |
J Invertebr Pathol |
10.1016/j.jip.2013.10.006 |
2014 |
* |
| Pathogenicity |
[Investigation of antimicrobial and antibiofilm effects of some preservatives used in drugs, cosmetics and food products]. |
Guven N, Kaynak Onurdag F |
Mikrobiyol Bul |
|
2014 |
* |
| Pathogenicity |
Antimicrobial activity of fluorescent Ag nanoparticles. |
Bera RK, Mandal SM, Raj CR |
Lett Appl Microbiol |
10.1111/lam.12222 |
2014 |
* |
| Genetics |
Genome Sequence of Pseudomonas aeruginosa Strain LCT-PA41, with Changed Metabolism after Space Flight. |
Liu C, Hu J, Fang X, Zhang D, Chang D, Wang J, Li T, Guo Y, Dai W, Liu C |
Genome Announc |
10.1128/genomeA.01124-13 |
2014 |
* |
| Pathogenicity |
Antibacterial activity of gemini quaternary ammonium salts. |
Oblak E, Piecuch A, Guz-Regner K, Dworniczek E |
FEMS Microbiol Lett |
10.1111/1574-6968.12331 |
2013 |
* |
| Pathogenicity |
Synthesis and in vitro analysis of novel dihydroxyacetophenone derivatives with antimicrobial and antitumor activities. |
Zbancioc AM, Miron A, Tuchilus C, Rotinberg P, Mihai CT, Mangalagiu II, Zbancioc G |
Med Chem |
10.2174/15734064113096660070 |
2014 |
* |
| Pathogenicity |
Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. |
Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE |
Toxicol Ind Health |
10.1177/0748233713498458 |
2013 |
* |
| Biotechnology |
Production of microbial medium from defatted brebra (Milletia ferruginea) seed flour to substitute commercial peptone agar. |
Andualem B, Gessesse A |
Asian Pac J Trop Biomed |
10.1016/S2221-1691(13)60157-4 |
2013 |
* |
| Pathogenicity |
Probiotic properties of lactobacilli species isolated from children's feces. |
Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yasar E |
Anaerobe |
10.1016/j.anaerobe.2013.09.006 |
2013 |
* |
| Pathogenicity |
The antimicrobial screening of a Barbadian medicinal plant with indications for use in the treatment of diabetic wound infections. |
Carrington S, Cohall DH, Gossell-Williams M, Lindo JF |
West Indian Med J |
10.7727/wimj.2011.223 |
2012 |
* |
| Pathogenicity |
Synthetic analogs of anoplin show improved antimicrobial activities. |
Munk JK, Uggerhoj LE, Poulsen TJ, Frimodt-Moller N, Wimmer R, Nyberg NT, Hansen PR |
J Pept Sci |
10.1002/psc.2548 |
2013 |
* |
| Pathogenicity |
The effects of preservation procedures on antibacterial property of amniotic membrane. |
Tehrani FA, Ahmadiani A, Niknejad H |
Cryobiology |
10.1016/j.cryobiol.2013.08.010 |
2013 |
* |
| Pathogenicity |
Antimicrobial activity of caO nanoparticles. |
Roy A, Gauri SS, Bhattacharya M, Bhattacharya J |
J Biomed Nanotechnol |
10.1166/jbn.2013.1681 |
2013 |
* |
| Phylogeny |
Antimicrobial potential of endophytic fungi derived from three seagrass species: Cymodocea serrulata, Halophila ovalis and Thalassia hemprichii. |
Supaphon P, Phongpaichit S, Rukachaisirikul V, Sakayaroj J |
PLoS One |
10.1371/journal.pone.0072520 |
2013 |
* |
| Pathogenicity |
Comparison of chlorine dioxide and dichloroisocyanurate disinfectants for use in the dental setting. |
Patel M, Ebonwu J, Cutler E |
SADJ |
|
2012 |
* |
| Pathogenicity |
Antimicrobial activity of green tea extract against isolates of methicillin-resistant Staphylococcus aureus and multi-drug resistant Pseudomonas aeruginosa. |
Radji M, Agustama RA, Elya B, Tjampakasari CR |
Asian Pac J Trop Biomed |
10.1016/S2221-1691(13)60133-1 |
2013 |
* |
| Metabolism |
Enzymatic degradation and bioactivity evaluation of C-6 oxidized chitosan. |
Pierre G, Salah R, Gardarin C, Traikia M, Petit E, Delort AM, Mameri N, Moulti-Mati F, Michaud P |
Int J Biol Macromol |
10.1016/j.ijbiomac.2013.06.025 |
2013 |
* |
| Pathogenicity |
[In vitro activity of Eucalyptus smithii and Juniperus communis essential oils against bacterial biofilms and efficacy perspectives of complementary inhalation therapy in chronic and recurrent upper respiratory tract infections]. |
Camporese A |
Infez Med |
|
2013 |
* |
| Pathogenicity |
Photodynamic effect of hypericin on the microorganisms and primary human fibroblasts. |
Kashef N, Borghei YS, Djavid GE |
Photodiagnosis Photodyn Ther |
10.1016/j.pdpdt.2012.11.007 |
2012 |
* |
| Enzymology |
Anti-infective potential of marine invertebrates and seaweeds from the Brazilian coast. |
Bianco EM, de Oliveira SQ, Rigotto C, Tonini ML, da Rosa Guimaraes T, Bittencourt F, Gouvea LP, Aresi C, de Almeida MT, Moritz MI, Martins CD, Scherner F, Carraro JL, Horta PA, Reginatto FH, Steindel M, Simoes CM, Schenkel EP |
Molecules |
10.3390/molecules18055761 |
2013 |
* |
| Phylogeny |
Development of a novel reverse transcriptase polymerase chain reaction to determine the Gram reaction and viability of bacteria in clinical specimens. |
Aarthi P, Bagyalakshmi R, Therese KL, Madhavan HN |
Microbiol Res |
10.1016/j.micres.2013.03.005 |
2013 |
* |
| Pathogenicity |
Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. |
Naghmouchi K, Baah J, Hober D, Jouy E, Rubrecht C, Sane F, Drider D |
Antimicrob Agents Chemother |
10.1128/AAC.02328-12 |
2013 |
* |
| Cultivation |
Three Pseudomonas aeruginosa strains with different protease profiles. |
Andrejko M, Zdybicka-Barabas A, Janczarek M, Cytrynska M |
Acta Biochim Pol |
2012_366 |
2013 |
* |
| Pathogenicity |
An investigation of the biochemical properties of tetrazines as potential coating additives. |
Jaiswal S, Varma PC, O'Neill L, Duffy B, McHale P |
Mater Sci Eng C Mater Biol Appl |
10.1016/j.msec.2012.12.094 |
2013 |
* |
| Pathogenicity |
Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial. |
Ross JE, Scangarella-Oman N, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2013.01.007 |
2013 |
* |
| Pathogenicity |
Antimicrobial activity of carboxymethyl chitosan/polyethylene oxide nanofibers embedded silver nanoparticles. |
Fouda MM, El-Aassar MR, Al-Deyab SS |
Carbohydr Polym |
10.1016/j.carbpol.2012.10.047 |
2012 |
* |
| Pathogenicity |
[Effect of Pseudomonas aeruginosa exometabolites on planktonic and biofilm cultures of Escherichia coli]. |
Kuznetsova MV, Karpunina TI, Maslennikova IL, Nesterova LIu, Demakov VA |
Zh Mikrobiol Epidemiol Immunobiol |
|
2012 |
* |
| Pathogenicity |
Zn(II), Ni(II), Cu(II) and Pb(II) complexes of tridentate asymmetrical Schiff base ligands: synthesis, characterization, properties and biological activity. |
Sahin M, Kocak N, Erdenay D, Arslan U |
Spectrochim Acta A Mol Biomol Spectrosc |
10.1016/j.saa.2012.11.006 |
2012 |
* |
| Metabolism |
Tissue distribution, expression, and antimicrobial activity of Anas platyrhynchos avian beta-defensin 6. |
Peng KS, Ruan LS, Tu J, Qi KZ, Jiang LH |
Poult Sci |
10.3382/ps.2012-02562 |
2013 |
* |
| Pathogenicity |
Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar. |
Justesen US, Acar Z, Olsson K, Jensen TG, Kerrn MB, Skov RL, Gahrn-Hansen B |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-012-1785-5 |
2012 |
* |
| Metabolism |
Attenuation of Pseudomonas aeruginosa virulence by marine invertebrate-derived Streptomyces sp. |
Naik DN, Wahidullah S, Meena RM |
Lett Appl Microbiol |
10.1111/lam.12034 |
2013 |
* |
| Genetics |
Effect of long-term starvation in salty microcosm on biofilm formation and motility in Pseudomonas aeruginosa. |
Elabed H, Maatallah M, Hamza R, Chakroun I, Bakhrouf A, Gaddour K |
World J Microbiol Biotechnol |
10.1007/s11274-012-1221-0 |
2012 |
* |
| Pathogenicity |
Optimized anti-pathogenic agents based on core/shell nanostructures and 2-((4-ethylphenoxy)ethyl)-N-(substituted-phenylcarbamothioyl)-benzamides. |
Limban C, Grumezescu AM, Saviuc C, Voicu G, Predan G, Sakizlian R, Chifiriuc MC |
Int J Mol Sci |
10.3390/ijms131012584 |
2012 |
* |
| Pathogenicity |
Fabrication, characterization and in vitro profile based interaction with eukaryotic and prokaryotic cells of alginate-chitosan-silica biocomposite. |
Balaure PC, Andronescu E, Grumezescu AM, Ficai A, Huang KS, Yang CH, Chifiriuc CM, Lin YS |
Int J Pharm |
10.1016/j.ijpharm.2012.10.045 |
2012 |
* |
| Pathogenicity |
[Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit]. |
Wang LJ, Sun Y, Song WL, Zhang ZJ, Liu CF |
Zhonghua Er Ke Za Zhi |
|
2012 |
* |
| Pathogenicity |
Antibacterial activity of the venom of Heterometrus xanthopus. |
Ahmed U, Mujaddad-Ur-Rehman M, Khalid N, Fawad SA, Fatima A |
Indian J Pharmacol |
10.4103/0253-7613.99332 |
2012 |
* |
| Pathogenicity |
Synergistic antibacterial activity of the essential oil of aguaribay (Schinus molle L.). |
de Mendonca Rocha PM, Rodilla JM, Diez D, Elder H, Guala MS, Silva LA, Pombo EB |
Molecules |
10.3390/molecules171012023 |
2012 |
* |
| Metabolism |
Antibiotic producing microorganisms from River Wiwi, Lake Bosomtwe and the Gulf of Guinea at Doakor Sea Beach, Ghana. |
Tawiah AA, Gbedema SY, Adu F, Boamah VE, Annan K |
BMC Microbiol |
10.1186/1471-2180-12-234 |
2012 |
* |
| Enzymology |
Inhibition of quorum sensing in Pseudomonas aeruginosa by sesquiterpene lactones. |
Amaya S, Pereira JA, Borkosky SA, Valdez JC, Bardon A, Arena ME |
Phytomedicine |
10.1016/j.phymed.2012.07.003 |
2012 |
* |
| Pathogenicity |
Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP). |
Marumo K, Komukai D, Hirose M, Nakamura H, Tanaka H, Ugajin K, Nagashima G, Yoshimura A |
J Infect Chemother |
10.1007/s10156-012-0456-x |
2012 |
* |
| Metabolism |
Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice. |
Jin L, Li J, Nation RL, Nicolazzo JA |
Antimicrob Agents Chemother |
10.1128/AAC.00713-12 |
2012 |
* |
| Pathogenicity |
Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives. |
Guzeldemirci NU, Satana D, Kucukbasmaci O |
J Enzyme Inhib Med Chem |
10.3109/14756366.2012.700926 |
2012 |
* |
| Pathogenicity |
In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. |
Vidaillac C, Benichou L, Duval RE |
Antimicrob Agents Chemother |
10.1128/AAC.05996-11 |
2012 |
* |
| Genetics |
Draft genome sequence of Pseudomonas aeruginosa strain ATCC 27853. |
Fang X, Fang Z, Zhao J, Zou Y, Li T, Wang J, Guo Y, Chang D, Su L, Ni P, Liu C |
J Bacteriol |
10.1128/JB.00690-12 |
2012 |
* |
| Pathogenicity |
Synergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibiotics. |
Stefanovic OD, Stanojevic DD, Comic LR |
Acta Pol Pharm |
|
2012 |
* |
| Pathogenicity |
Essential oil composition and antibacterial activity of Monticalia greenmaniana (Asteraceae). |
Cardenas J, Rojas J, Rojas-Fermin L, Lucena M, Buitrago A |
Nat Prod Commun |
|
2012 |
* |
| Pathogenicity |
In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement. |
Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA |
J Orthop Traumatol |
10.1007/s10195-012-0191-1 |
2012 |
* |
| Pathogenicity |
Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C. |
Masadeh MM, Mhaidat NM, Alzoubi KH, Al-Azzam SI, Shaweesh AI |
Curr Microbiol |
10.1007/s00284-012-0094-7 |
2012 |
* |
| Enzymology |
Antimicrobial activity of a 48-kDa protease (AMP48) from Artocarpus heterophyllus latex. |
Siritapetawee J, Thammasirirak S, Samosornsuk W |
Eur Rev Med Pharmacol Sci |
|
2012 |
* |
| Pathogenicity |
New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation. |
Barbuceanu SF, Saramet G, Almajan GL, Draghici C, Barbuceanu F, Bancescu G |
Eur J Med Chem |
10.1016/j.ejmech.2012.01.031 |
2012 |
* |
| Pathogenicity |
In vitro microbiology studies on a new peritoneal dialysis connector. |
Di Bonaventura G, Cerasoli P, Pompilio A, Arrizza F, Di Liberato L, Stingone A, Sirolli V, Arduini A, Bonomini M |
Perit Dial Int |
10.3747/pdi.2011.00089 |
2012 |
* |
| Pathogenicity |
Antibacterial and antioxidant activities of three endemic plants from Algerian Sahara. |
Bouchouka E, Djilani A, Bekkouche A |
Acta Sci Pol Technol Aliment |
973178 |
2012 |
* |
| Pathogenicity |
Antimicrobial activity of Carpolobia lutea extracts and fractions. |
Nwidu LL, Nwafor PA, Vilegas W |
Afr J Tradit Complement Altern Med |
|
2012 |
* |
| Pathogenicity |
Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa. |
Hirakata Y, Yano H, Arai K, Kitagawa M, Hatta M, Kunishima H, Kaku M |
J Infect Chemother |
10.1007/s10156-011-0342-y |
2011 |
* |
| Enzymology |
Antimicrobial effect of statins: organic solvents might falsify microbiological testing results. |
Matzneller P, Manafi M, Zeitlinger M |
Int J Clin Pharmacol Ther |
10.5414/cp201581 |
2011 |
* |
| Pathogenicity |
[Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates]. |
Acuner IC, Bayramoglu G, Birinci A, Cekic Cihan C, Bek Y, Durupinar B |
Mikrobiyol Bul |
|
2011 |
* |
| Pathogenicity |
Suitability of a new antimicrobial aminosterol formulation for aerosol delivery in cystic fibrosis. |
Alhanout K, Brunel JM, Dubus JC, Rolain JM, Andrieu V |
J Antimicrob Chemother |
10.1093/jac/dkr380 |
2011 |
* |
| Pathogenicity |
[Antibacterial activity of nanostructured silver gel]. |
Chervinets VM, Bondarenko VM, Chervinets IuV, Ovchinnikov MM, Samoukina AM, Mikhailova ES, Petrova MB, Kharitonova EA, Briantseva VM |
Zh Mikrobiol Epidemiol Immunobiol |
|
2011 |
* |
| Pathogenicity |
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. |
Bergen PJ, Tsuji BT, Bulitta JB, Forrest A, Jacob J, Sidjabat HE, Paterson DL, Nation RL, Li J |
Antimicrob Agents Chemother |
10.1128/AAC.05298-11 |
2011 |
* |
| Pathogenicity |
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. |
Bergen PJ, Forrest A, Bulitta JB, Tsuji BT, Sidjabat HE, Paterson DL, Li J, Nation RL |
Antimicrob Agents Chemother |
10.1128/AAC.05028-11 |
2011 |
* |
| Pathogenicity |
Investigation of the antimicrobial activity of Rhaponticum (Rhaponticum carthamoides D.C. Iljin) and shrubby cinquefoil (Potentilla fruticosa L.). |
Jurkstiene V, Pavilonis A, Garsviene D, Juozulynas A, Samsoniene L, Dauksiene D, Jankauskiene K, Simoniene-Kazlauskiene G, Stankevicius E |
Medicina (Kaunas) |
1103-06e |
2011 |
* |
| Pathogenicity |
Effects of ozone on membrane permeability and ultrastructure in Pseudomonas aeruginosa. |
Zhang YQ, Wu QP, Zhang JM, Yang XH |
J Appl Microbiol |
10.1111/j.1365-2672.2011.05113.x |
2011 |
* |
| Pathogenicity |
In vitro antibacterial effect of aqueous and ethanolic Moringa leaf extracts. |
Peixoto JR, Silva GC, Costa RA, de Sousa Fontenelle JR, Vieira GH, Filho AA, dos Fernandes Vieira RH |
Asian Pac J Trop Med |
10.1016/S1995-7645(11)60069-2 |
2011 |
* |
| Pathogenicity |
[Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa]. |
Liu MT, Sheng MY, Zhang Y, Li Y |
Zhonghua Yi Xue Za Zhi |
|
2011 |
* |
| Pathogenicity |
Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone. |
Ross JE, Liverman LC, Jones RN |
J Clin Microbiol |
10.1128/JCM.00636-11 |
2011 |
* |
| Biotechnology |
[Reproduction of a rat model of burn with infection]. |
Zhang DW, Gong ZY, Peng YZ |
Zhonghua Shao Shang Za Zhi |
|
2011 |
* |
| Enzymology |
Essential oil composition and antibacteral activity of Vismia baccifera fruits collected from Merida, Venezuela. |
Rojas J, Buitrago A, Rojas L, Morales A, Lucena M, Baldovino S |
Nat Prod Commun |
|
2011 |
* |
| Pathogenicity |
In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf. |
Tajbakhsh S, Pouyan M, Zandi K, Bahramian P, Sartavi K, Fouladvand M, Asayesh G, Barazesh A |
Eur Rev Med Pharmacol Sci |
|
2011 |
* |
| Pathogenicity |
In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology. |
Kresken M, Korber-Irrgang B, Lauffer J, Decker-Burgard S, Davies T |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2011.01.028 |
2011 |
* |
| Pathogenicity |
Antibacterial and antifungal activities from Siamese crocodile blood. |
Leelawongtawon R, Siruntawineti J, Chaeychomsri W, Sattaponpan C |
J Med Assoc Thai |
|
2010 |
* |
| Pathogenicity |
Antioxidant and antibacterial activities of selected varieties of thai mango seed extract. |
Khammuang S, Sarnthima R |
Pak J Pharm Sci |
|
2011 |
* |
| Pathogenicity |
The effect of manuka honey on the structure of Pseudomonas aeruginosa. |
Henriques AF, Jenkins RE, Burton NF, Cooper RA |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-010-1065-1 |
2010 |
* |
| Pathogenicity |
Antibacterial effect of lanthanum calcium manganate (La0.67Ca0.33MnO3) nanoparticles against Pseudomonas aeruginosa ATCC 27853. |
De D, Mandal SM, Gauri SS, Bhattacharya R, Ram S, Roy SK |
J Biomed Nanotechnol |
10.1166/jbn.2010.1113 |
2010 |
* |
| Cultivation |
Influence of Legionella pneumophila and other water bacteria on the survival and growth of Acanthamoeba polyphaga. |
Anacarso I, Guerrieri E, Bondi M, de Niederhausern S, Iseppi R, Sabia C, Contri M, Borella P, Messi P |
Arch Microbiol |
10.1007/s00203-010-0618-0 |
2010 |
* |
| Pathogenicity |
In-vitro antibacterial activity of selected medicinal plants from Longisa region of Bomet district, Kenya. |
Cheruiyot KR, Olila D, Kateregga J |
Afr Health Sci |
|
2009 |
* |
| Enzymology |
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. |
Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL |
Antimicrob Agents Chemother |
10.1128/AAC.00903-09 |
2010 |
* |
| Pathogenicity |
Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. |
Naenna P, Noisumdaeng P, Pongpech P, Tribuddharat C |
Southeast Asian J Trop Med Public Health |
|
2010 |
* |
| Pathogenicity |
Absence of bacterial resistance to medical-grade manuka honey. |
Cooper RA, Jenkins L, Henriques AF, Duggan RS, Burton NF |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-010-0992-1 |
2010 |
* |
| Phylogeny |
Chemical composition and antimicrobial activity of essential oils of Genista ulicina and G. vepres. |
Lograda T, Chaker AN, Chalchat JC, Ramdani M, Silini H, Figueredo G, Chalarde P |
Nat Prod Commun |
|
2010 |
* |
| Pathogenicity |
Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil. |
Bouhdid S, Abrini J, Amensour M, Zhiri A, Espuny MJ, Manresa A |
J Appl Microbiol |
10.1111/j.1365-2672.2010.04740.x |
2010 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of novel Ag-N-hetero-cyclic carbene complexes. |
Ozdemir I, Ozcan EO, Gunal S, Gurbuz N |
Molecules |
10.3390/molecules15042499 |
2010 |
* |
| Pathogenicity |
[Investigation of antibacterial activity of sertralin]. |
Coban AY, Tanriverdi Cayci Y, Keles Uludag S, Durupinar B |
Mikrobiyol Bul |
|
2009 |
* |
| Pathogenicity |
Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. |
Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP |
Eur J Med Chem |
10.1016/j.ejmech.2009.12.030 |
2009 |
* |
| Pathogenicity |
Chemical composition and antibacterial activity of the essential oil of Monticalia andicola (Asteraceae) collected in Venezuela. |
Baldovino S, Rojas J, Rojas LB, Lucena M, Buitrago A, Morales A |
Nat Prod Commun |
|
2009 |
* |
| Pathogenicity |
Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci. |
Mueller-Premru M, Zidar N, Spik VC, Krope A, Kikelj D |
Chemotherapy |
10.1159/000263228 |
2009 |
* |
| Enzymology |
The in-vitro antimicrobial activity of some medicinal plants against beta-lactam-resistant bacteria. |
Gangoue-Pieboji J, Eze N, Ngongang Djintchui A, Ngameni B, Tsabang N, Pegnyemb DE, Biyiti L, Ngassam P, Koulla-Shiro S, Galleni M |
J Infect Dev Ctries |
10.3855/jidc.77 |
2009 |
* |
| Metabolism |
Proteomic change of peripheral lymphocytes from scald injury and Pseudomonas aeruginosa sepsis in rabbits. |
Zhang PH, Yang LR, Li LL, Zeng JZ, Ren LC, Liang PF, Huang XY |
Burns |
10.1016/j.burns.2009.03.006 |
2009 |
* |
| Enzymology |
Composition, antioxidant and antimicrobial activities of the essential oil of Marrubium deserti. |
Laouer H, Yabrir B, Djeridane A, Yousfi M, Beldovini N, Lamamra M |
Nat Prod Commun |
|
2009 |
* |
| Pathogenicity |
The in vitro antimicrobial activities of the essential oils of some Lamiaceae species from Turkey. |
Sarac N, Ugur A |
J Med Food |
10.1089/jmf.2008.0089 |
2009 |
* |
| Metabolism |
[Daily dynamics of particular pathogenicity factors and persistence of Staphylococcus aureus under the influence of exametabolites of associative microflora]. |
Timokhina TKh |
Zh Mikrobiol Epidemiol Immunobiol |
|
2009 |
* |
| Metabolism |
[Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and Pseudomonas aeruginosa sepsis]. |
Zeng JZ, Zhang PH, Li LL, Ren LC, Liang PF, Huang XY |
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue |
|
2009 |
* |
| Pathogenicity |
Tocopherol, carotene, phenolic contents and antibacterial properties of rose essential oil, hydrosol and absolute. |
Ulusoy S, Bosgelmez-Tinaz G, Secilmis-Canbay H |
Curr Microbiol |
10.1007/s00284-009-9475-y |
2009 |
* |
| Pathogenicity |
The occurrence of multidrug-resistant Pseudomonas aeruginosa on hydrocarbon-contaminated sites. |
Kaszab E, Kriszt B, Atzel B, Szabo G, Szabo I, Harkai P, Szoboszlay S |
Microb Ecol |
10.1007/s00248-009-9551-7 |
2009 |
* |
| Pathogenicity |
Screening of some Kenyan medicinal plants for antibacterial activity. |
Wagate CG, Mbaria JM, Gakuya DW, Nanyingi MO, Kareru PG, Njuguna A, Gitahi N, Macharia JK, Njonge FK |
Phytother Res |
10.1002/ptr.2866 |
2010 |
* |
| Pathogenicity |
Purification and characterization of a new L-amino acid oxidase from Daboia russellii siamensis venom. |
Zhong SR, Jin Y, Wu JB, Jia YH, Xu GL, Wang GC, Xiong YL, Lu QM |
Toxicon |
10.1016/j.toxicon.2009.06.004 |
2009 |
* |
| Pathogenicity |
[Antimicrobial activities of the culture supernatant of 293 cells transfected with recombinant HBD-2 gene eukyriotic expressive plasmid]. |
Wang H, Dong B, Zhou Y |
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi |
|
2009 |
* |
| Enzymology |
Enzymatic characterization of 30 kDa lipase from Pseudomonas aeruginosa ATCC 27853. |
Izrael-Zivkovic LT, Gojgic-Cvijovic GD, Gopcevic KR, Vrvic MM, Karadzic IM |
J Basic Microbiol |
10.1002/jobm.200800229 |
2009 |
* |
| Pathogenicity |
Composition and antimicrobial activity of Marrubium incanum Desr. (Lamiaceae) essential oil. |
Petrovic S, Pavlovic M, Maksimovic Z, Milenkovic M, Couladis M, Tzakouc O, Niketic M |
Nat Prod Commun |
|
2009 |
* |
| Pathogenicity |
Effects of multipurpose contact-lens care solutions on adhesion of Pseudomonas aeruginosa to corneal epithelial cells. |
Imayasu M, Shimizu H, Shimada S, Suzuki T, Cavanagh HD |
Eye Contact Lens |
10.1097/ICL.0b013e31819a67fd |
2009 |
* |
| Pathogenicity |
Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil. |
Bouhdid S, Abrini J, Zhiri A, Espuny MJ, Manresa A |
J Appl Microbiol |
10.1111/j.1365-2672.2008.04124.x |
2009 |
* |
| Pathogenicity |
Antimicrobial activity of endodontic sealers based on calcium hydroxide and MTA. |
Tanomaru JM, Tanomaru-Filho M, Hotta J, Watanabe E, Ito IY |
Acta Odontol Latinoam |
|
2008 |
* |
| Phylogeny |
Additive activity of royal jelly and honey against Pseudomonas aeruginosa. |
Boukraa L |
Altern Med Rev |
|
2008 |
* |
| Pathogenicity |
[Antimicrobial activity of soft and purified propolis extracts]. |
Pavilonis A, Baranauskas A, Puidokaite L, Mazeliene Z, Savickas A, Radziunas R |
Medicina (Kaunas) |
0812-09l |
2008 |
* |
| Pathogenicity |
Structure-activity relationship of antibacterial chalcones. |
Avila HP, Smania Ede F, Monache FD, Smania A Jr |
Bioorg Med Chem |
10.1016/j.bmc.2008.09.064 |
2008 |
* |
| Pathogenicity |
Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro. |
Romero IL, Paiato TP, Silva CB, Nigro JB, Malta S, Jenne Mimica LM, Soong HK, Hida RY |
Curr Eye Res |
10.1080/02713680802437692 |
2008 |
* |
| Pathogenicity |
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa. |
Bulitta JB, Ly NS, Yang JC, Forrest A, Jusko WJ, Tsuji BT |
Antimicrob Agents Chemother |
10.1128/AAC.00489-08 |
2008 |
* |
| Pathogenicity |
Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes. |
Fontanay S, Grare M, Mayer J, Finance C, Duval RE |
J Ethnopharmacol |
10.1016/j.jep.2008.09.001 |
2008 |
* |
| Pathogenicity |
Antimicrobial activities of the essential oils of Origanum onites L., Origanum vulgare L. subspecies hirtum (Link) Ietswaart, Satureja thymbra L., and Thymus cilicicus Boiss. & Bal. growing wild in Turkey. |
Sarac N, Ugur A |
J Med Food |
10.1089/jmf.2007.0520 |
2008 |
* |
| Pathogenicity |
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. |
Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Mocchegiani F, Chiodi L, Castelletti S, Gabrielli E, Saba V, Scalise G, Giacometti A |
J Antimicrob Chemother |
10.1093/jac/dkn393 |
2008 |
* |
| Pathogenicity |
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. |
Tam VH, Ledesma KR, Vo G, Kabbara S, Lim TP, Nikolaou M |
Antimicrob Agents Chemother |
10.1128/AAC.01468-07 |
2008 |
* |
| Pathogenicity |
Antibacterial and antifungal properties of human cerumen. |
Lum CL, Jeyanthi S, Prepageran N, Vadivelu J, Raman R |
J Laryngol Otol |
10.1017/S0022215108003307 |
2008 |
* |
| Pathogenicity |
Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coil isolates recovered from 80 Ontario swine farms. |
Varela NP, Friendship R, Dewey C, Valdivieso A |
Can J Vet Res |
|
2008 |
* |
| Cultivation |
Variation of the adhesion to polystyrene of phenotypic mutants of Pseudomonas aeruginosa ATCC 27853 during starvation conditions. |
Cappello S |
New Microbiol |
|
2008 |
* |
| Metabolism |
Growth-inhibitory effects of sulfonamides at different pH: dissimilar susceptibility patterns of a soil bacterium and a test bacterium used for antibiotic assays. |
Tappe W, Zarfl C, Kummer S, Burauel P, Vereecken H, Groeneweg J |
Chemosphere |
10.1016/j.chemosphere.2008.02.041 |
2008 |
* |
| Pathogenicity |
Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. |
Ryge TS, Frimodt-Moller N, Hansen PR |
Chemotherapy |
10.1159/000119707 |
2008 |
* |
| Genetics |
Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. |
Giske CG, Buaro L, Sundsfjord A, Wretlind B |
Microb Drug Resist |
10.1089/mdr.2008.0778 |
2008 |
* |
| Pathogenicity |
Synergistic action of starch and honey against Pseudomonas aeruginosa in correlation with diastase number. |
Boukraa L, Benbarek H, Aissat S |
J Altern Complement Med |
10.1089/acm.2007.0589 |
2008 |
* |
| Pathogenicity |
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. |
Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW |
J Antimicrob Chemother |
10.1093/jac/dkm511 |
2008 |
* |
| Enzymology |
[Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension]. |
Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N |
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi |
|
2006 |
* |
| Pathogenicity |
In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. |
Grare M, Mourer M, Fontanay S, Regnouf-de-Vains JB, Finance C, Duval RE |
J Antimicrob Chemother |
10.1093/jac/dkm244 |
2007 |
* |
| Metabolism |
[BCG cell wall proteins enhance clearance of Pseudomonas aeruginosa in rat lungs]. |
Liu XK, Zhou H, Huang N, Zhu BD, Feng Y, Wu Q, Wang BY |
Sichuan Da Xue Xue Bao Yi Xue Ban |
|
2007 |
* |
| Pathogenicity |
Effect of shear stress on growth, adhesion and biofilm formation of Pseudomonas aeruginosa with antibiotic-induced morphological changes. |
Fonseca AP, Sousa JC |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2007.04.011 |
2007 |
* |
| Biotechnology |
The identification of antibacterial compounds for the development of enhanced media for the detection of foodborne fungi. |
Tournas VH, Kohn JS, Katsoudas EJ |
Int J Food Microbiol |
10.1016/j.ijfoodmicro.2007.04.013 |
2007 |
* |
| Cultivation |
Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. |
Brown SD, Traczewski MM |
J Clin Microbiol |
10.1128/JCM.02351-06 |
2007 |
* |
| Pathogenicity |
In vitro antimicrobial activity of endodontic sealers, MTA-based cements and Portland cement. |
Tanomaru-Filho M, Tanomaru JM, Barros DB, Watanabe E, Ito IY |
J Oral Sci |
10.2334/josnusd.49.41 |
2007 |
* |
| Pathogenicity |
In vitro antimicrobial activity of different gutta-percha points and calcium hydroxide pastes. |
Tanomaru JM, Pappen FG, Tanomaru Filho M, Spolidorio DM, Ito IY |
Braz Oral Res |
10.1590/s1806-83242007000100006 |
2007 |
* |
| Pathogenicity |
Amikacin-loaded vascular prosthesis as an effective drug carrier. |
Ginalska G, Kowalczuk D, Osinska M |
Int J Pharm |
10.1016/j.ijpharm.2007.02.016 |
2007 |
* |
| Pathogenicity |
Antimicrobial activity and pollen composition of honey samples collected from different provinces in Turkey. |
Mercan N, Guvensen A, Celik A, Katircioglu H |
Nat Prod Res |
10.1080/14786410600906277 |
2007 |
* |
| Enzymology |
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. |
Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW |
Clin Microbiol Infect |
10.1111/j.1469-0691.2006.01674.x |
2007 |
* |
| Pathogenicity |
CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo. |
Kim J, Ha JR, Oh SW, Kim HG, Lee JM, Lee DG, Lee SH, Kim JG |
Biol Pharm Bull |
10.1248/bpb.30.575 |
2007 |
* |
| Enzymology |
Decaspirones F-I, bioactive secondary metabolites from the saprophytic fungus Helicoma viridis. |
Hu H, Guo H, Li E, Liu X, Zhou Y, Che Y |
J Nat Prod |
10.1021/np0603830 |
2006 |
* |
| Pathogenicity |
[Towards new antibacterial drugs. Interest of para-guanidinoethylcalix[4]arene]. |
Grare M, Mourer M, Regnouf de Vains JB, Finance C, Duval RE |
Pathol Biol (Paris) |
10.1016/j.patbio.2006.07.022 |
2006 |
* |
| Pathogenicity |
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp. |
Tong W, Wang R, Chai D, Li Z, Pei F |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2006.08.008 |
2006 |
* |
| Pathogenicity |
Screening antimicrobial activity of various extracts of Artemisia dracunculus L. |
Benli M, Kaya I, Yigit N |
Cell Biochem Funct |
10.1002/cbf.1373 |
2007 |
* |
| Pathogenicity |
Antibacterial activity of some unsymmetrical diorganyltellurium(IV) dichlorides. |
Soni D, Gupta PK, Kumar Y, Chandrashekhar TG |
Indian J Biochem Biophys |
|
2005 |
* |
| Pathogenicity |
Antibacterial activity of crude methanolic extract and its fractions of aerial parts of Anthemis tinctoria. |
Akgul C, Saglikoglu G |
Indian J Biochem Biophys |
|
2005 |
* |
| Pathogenicity |
[Antimicrobial susceptibility in Pseudomonas aeruginosa strains taken from patients with cystic fibrosis]. |
Perez Monras MF, Batlle Almodovar Mdel C, Verdera Hernandez J, Hernandez AL |
Rev Cubana Med Trop |
|
2006 |
* |
| Pathogenicity |
Effect of neuraminidase on adherence of Pseudomonas aeruginosa to human buccal epithelial cells. Inhibition of adhesion by monosaccharides. |
Wolska K, Zabielska K, Jakubczak A |
Pol J Microbiol |
|
2006 |
* |
| Pathogenicity |
Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. |
Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA |
Antimicrob Agents Chemother |
10.1128/AAC.01165-05 |
2006 |
* |
| Pathogenicity |
Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens. |
de Almeida Manzano RP, Naufal SC, Hida RY, Guarnieri LO, Nishiwaki-Dantas MC |
Cornea |
10.1097/01.ico.0000183490.16131.e3 |
2006 |
* |
| Pathogenicity |
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. |
Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2005.10.012 |
2006 |
* |
| Pathogenicity |
[Multiresistant Pseudomonas spp. in vitro susceptibility to a combination of two antibiotics]. |
Pliego-Castaneda QF, Yanez-Viguri JA, Lopez-Valle T |
Cir Cir |
|
2005 |
* |
| Pathogenicity |
Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. |
Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC |
Mem Inst Oswaldo Cruz |
10.1590/s0074-02762005000700018 |
2006 |
* |
| Pathogenicity |
Flavonoid analysis and antimicrobial activity of commercially available propolis products. |
Kosalec I, Pepeljnjak S, Bakmaz M, Vladimir-Knezevic S |
Acta Pharm |
|
2005 |
* |
| Pathogenicity |
Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines. |
Tiwari RK, Singh D, Singh J, Chhillar AK, Chandra R, Verma AK |
Eur J Med Chem |
10.1016/j.ejmech.2005.10.010 |
2005 |
* |
| Phylogeny |
Isolation of DNA for PCR assays from noncultivable Campylobacter jejuni isolates. |
Callicott KA, Stern NJ, Hiett KL |
Poult Sci |
10.1093/ps/84.10.1530 |
2005 |
* |
| Pathogenicity |
Antibacterial activity of coumarins. |
de Souza SM, Delle Monache F, Smania A Jr |
Z Naturforsch C J Biosci |
10.1515/znc-2005-9-1006 |
2005 |
* |
| Pathogenicity |
In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms. |
Agarwal G, Kapil A, Kabra SK, Das BK, Dwivedi SN |
Natl Med J India |
|
2005 |
* |
| Pathogenicity |
Synthesis and evaluation of analgesic/ anti-inflammatory and antimicrobial activities of 3-substituted- 1,2,4-triazole-5-thiones. |
Tozkoparan B, Kupeli E, Yesilada E, Isik S, Ozalp M, Ertan M |
Arzneimittelforschung |
10.1055/s-0031-1296901 |
2005 |
* |
| Enzymology |
Purification of bovine milk lactoperoxidase and investigation of antibacterial properties at different thiocyanate mediated. |
Uguz MT, Ozdemir H |
Prikl Biokhim Mikrobiol |
|
2005 |
* |
| Pathogenicity |
HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes? |
Feng Y, Huang N, Wu Q, Wang B |
J Leukoc Biol |
10.1189/jlb.0505280 |
2005 |
* |
| Pathogenicity |
High-throughput metal susceptibility testing of microbial biofilms. |
Harrison JJ, Turner RJ, Ceri H |
BMC Microbiol |
10.1186/1471-2180-5-53 |
2005 |
* |
| Pathogenicity |
Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue. |
Joukhadar C, Dehghanyar P, Traunmuller F, Sauermann R, Mayer-Helm B, Georgopoulos A, Muller M |
Antimicrob Agents Chemother |
10.1128/AAC.49.10.4149-4153.2005 |
2005 |
* |
| Pathogenicity |
[Establishing a model of neutropenia rat with Pseudomonas aeruginosa pneumonia and a study on its inflammatory reaction]. |
Li Z, Qu J, He L |
Zhonghua Jie He He Hu Xi Za Zhi |
|
2001 |
* |
| Pathogenicity |
Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. |
Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K, Kikuchi Y, Kuratsuji T, Kirikae T |
Antimicrob Agents Chemother |
10.1128/AAC.49.9.3734-3742.2005 |
2005 |
* |
| Pathogenicity |
Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2). |
Feng Y, Huang N, Wu Q, Bao L, Wang BY |
Acta Pharmacol Sin |
10.1111/j.1745-7254.2005.00132.x |
2005 |
* |
| Pathogenicity |
In vitro antimicrobial activity of Fill Canal, Sealapex, Mineral Trioxide Aggregate, Portland cement and EndoRez. |
Sipert CR, Hussne RP, Nishiyama CK, Torres SA |
Int Endod J |
10.1111/j.1365-2591.2005.00984.x |
2005 |
* |
| Pathogenicity |
Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. |
Harrison JJ, Turner RJ, Ceri H |
Environ Microbiol |
10.1111/j.1462-2920.2005.00777.x |
2005 |
* |
| Enzymology |
The efficacy of piperacillin/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: a histopathological and microbiological evaluation. |
Ozkiris A, Evereklioglu C, Esel D, Akgun H, Goktas S, Erkilic K |
Curr Eye Res |
10.1080/02713680490894180 |
2005 |
* |
| Pathogenicity |
Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. |
Leitao DP, Polizello AC, Ito IY, Spadaro AC |
J Med Food |
10.1089/jmf.2005.8.36 |
2005 |
* |
| Pathogenicity |
Activity of histone H1.2 in infected burn wounds. |
Jacobsen F, Baraniskin A, Mertens J, Mittler D, Mohammadi-Tabrisi A, Schubert S, Soltau M, Lehnhardt M, Behnke B, Gatermann S, Steinau HU, Steinstraesser L |
J Antimicrob Chemother |
10.1093/jac/dki067 |
2005 |
* |
| Pathogenicity |
Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components. |
Li RC, Tang MC |
J Antimicrob Chemother |
10.1093/jac/dki035 |
2005 |
* |
| Pathogenicity |
Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials. |
Gonzalez-Diaz H, Torres-Gomez LA, Guevara Y, Almeida MS, Molina R, Castanedo N, Santana L, Uriarte E |
J Mol Model |
10.1007/s00894-004-0228-3 |
2005 |
* |
| Pathogenicity |
[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community]. |
Weber P, Dib C, Durand C, Moniot-Ville N |
Pathol Biol (Paris) |
10.1016/j.patbio.2004.03.015 |
2005 |
* |
| Pathogenicity |
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. |
Jones RN, Anderegg TR, Swenson JM |
J Clin Microbiol |
10.1128/JCM.43.2.925-927.2005 |
2005 |
* |
| Pathogenicity |
Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones. |
Lattmann E, Dunn S, Niamsanit S, Sattayasai N |
Bioorg Med Chem Lett |
10.1016/j.bmcl.2004.12.051 |
2005 |
* |
| Pathogenicity |
Antimicrobial activity and chemical investigation of Brazilian Drosera. |
Ferreira DT, Andrei CC, Saridakis HO, Faria Tde J, Vinhato E, Carvalho KE, Daniel JF, Machado SL, Saridakis DP, Braz-Filho R |
Mem Inst Oswaldo Cruz |
10.1590/s0074-02762004000700016 |
2005 |
* |
| Enzymology |
Characterization and antimicrobial activity of bacteriocin 217 produced by natural isolate Lactobacillus paracasei subsp. paracasei BGBUK2-16. |
Lozo J, Vukasinovic M, Strahinic I, Topisirovic L |
J Food Prot |
10.4315/0362-028x-67.12.2727 |
2004 |
* |
| Pathogenicity |
Biofilm susceptibility to metal toxicity. |
Harrison JJ, Ceri H, Stremick CA, Turner RJ |
Environ Microbiol |
10.1111/j.1462-2920.2004.00656.x |
2004 |
* |
| Pathogenicity |
Syntheses, in vitro antibacterial and cytotoxic activities of a series of 3-substituted succinimides. |
Zentz F, Le Guillou R, Labia R, Sirot D, Linard B, Valla A |
Farmaco |
10.1016/j.farmac.2004.07.007 |
2004 |
* |
| Metabolism |
Microbial synthesis of poly(3-hydroxyalkanoates) by Pseudomonas aeruginosa from fatty acids: identification of higher monomer units and structural characterization. |
Barbuzzi T, Giuffrida M, Impallomeni G, Carnazza S, Ferreri A, Guglielmino SP, Ballistreri A |
Biomacromolecules |
10.1021/bm049583l |
2004 |
* |
| Phylogeny |
Streptomyces africanus sp. nov., a novel streptomycete with blue aerial mycelium. |
Meyers PR, Goodwin CM, Bennett JA, Aken BL, Price CE, van Rooyen JM |
Int J Syst Evol Microbiol |
10.1099/ijs.0.02738-0 |
2004 |
* |
| Pathogenicity |
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. |
Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G |
J Antimicrob Chemother |
10.1093/jac/dkh381 |
2004 |
* |
| Pathogenicity |
Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa. |
Fonseca AP, Extremina C, Fonseca AF, Sousa JC |
J Med Microbiol |
10.1099/jmm.0.45637-0 |
2004 |
* |
| Metabolism |
Comparative biodegradation examination of Pseudomonas aeruginosa (ATCC 27853) and other oil degraders on hydrocarbon contaminated soil. |
Szoboszlay S, Atzel B, Kriszt B |
Commun Agric Appl Biol Sci |
|
2003 |
* |
| Pathogenicity |
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. |
Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D'Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G |
J Infect Dis |
10.1086/421913 |
2004 |
* |
| Metabolism |
Differences in biofilm and planktonic cell mediated reduction of metalloid oxyanions. |
Harrison JJ, Ceri H, Stremick C, Turner RJ |
FEMS Microbiol Lett |
10.1016/j.femsle.2004.05.005 |
2004 |
* |
| Cultivation |
Synthesis and antibacterial activities of new bis-benzimidazoles. |
Kucukbay H, Durmaz R, Okuyucu N, Gunal S, Kazaz C |
Arzneimittelforschung |
10.1055/s-0031-1296938 |
2004 |
* |
| Pathogenicity |
PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities. |
Yang YX, Feng Y, Wang BY, Wu Q |
Acta Pharmacol Sin |
|
2004 |
* |
| Pathogenicity |
Essential oil analysis and antimicrobial activity of eight Stachys species from Greece. |
Skaltsa HD, Demetzos C, Lazari D, Sokovic M |
Phytochemistry |
10.1016/s0031-9422(03)00386-8 |
2003 |
* |
| Pathogenicity |
Bacterial reduction by cell salvage washing and leukocyte depletion filtration. |
Waters JH, Tuohy MJ, Hobson DF, Procop G |
Anesthesiology |
10.1097/00000542-200309000-00021 |
2003 |
* |
| Metabolism |
Enhanced microbial biomass assay using mutant luciferase resistant to benzalkonium chloride. |
Hattori N, Sakakibara T, Kajiyama N, Igarashi T, Maeda M, Murakami S |
Anal Biochem |
10.1016/s0003-2697(03)00322-1 |
2003 |
* |
| Pathogenicity |
Screening of anti-bacterial activity of medicinal plants from Belize (Central America). |
Camporese A, Balick MJ, Arvigo R, Esposito RG, Morsellino N, De Simone F, Tubaro A |
J Ethnopharmacol |
10.1016/s0378-8741(03)00115-6 |
2003 |
* |
| Pathogenicity |
Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio. |
White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA |
Pharmacotherapy |
10.1592/phco.23.5.603.32193 |
2003 |
* |
| Enzymology |
In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate. |
Desai TR, Tyrrell GJ, Ng T, Finlay WH |
Pharm Res |
10.1023/a:1022664406840 |
2003 |
* |
| Pathogenicity |
[Isolation, purification and antibacterial activities of salivary histidine-rich polypeptides]. |
Luo H, Huang N, Yang M, Tang B, Wu Q, Wang B |
Hua Xi Kou Qiang Yi Xue Za Zhi |
|
1999 |
* |
| Cultivation |
Morphologic variations in bacteria under stress conditions: near-field optical studies. |
Cefali E, Patane S, Arena A, Saitta G, Guglielmino S, Cappello S, Nicolo M, Allegrini M |
Scanning |
10.1002/sca.4950240601 |
2002 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity evaluation of some new adamantane derivatives. |
Calis U, Yarim M, Koksal M, Ozalp M |
Arzneimittelforschung |
|
2002 |
* |
| Metabolism |
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. |
Omri A, Suntres ZE, Shek PN |
Biochem Pharmacol |
10.1016/s0006-2952(02)01346-1 |
2002 |
* |
| Pathogenicity |
Re-evaluations of disk diffusion quality control ranges for 11 drugs: report from the QC working group of the national committee for clinical laboratory standards. |
Jones RN, Cullen S |
Int J Antimicrob Agents |
10.1016/s0924-8579(02)00184-x |
2002 |
* |
| Pathogenicity |
Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection. |
Bonapace CR, Friedrich LV, Bosso JA, White RL |
Antimicrob Agents Chemother |
10.1128/AAC.46.11.3574-3579.2002 |
2002 |
* |
| Pathogenicity |
Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. |
Mathur P, Kapil A, Das B, Dhawan B |
Indian J Med Res |
|
2002 |
* |
| Pathogenicity |
Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts. |
Cetinkaya E, Denizci A, Ozdemir I, Ozturk HT, Karaboz I, Cetinkaya B |
J Chemother |
10.1179/joc.2002.14.3.241 |
2002 |
* |
| Pathogenicity |
Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives. |
Raffa D, Migliara O, Daidone G, Maggio B, Schillaci D |
Boll Chim Farm |
|
2002 |
* |
| Pathogenicity |
Synthesis and antimicrobial activities of N-substituted imides. |
Zentz F, Valla A, Le Guillou R, Labia R, Mathot AG, Sirot D |
Farmaco |
10.1016/s0014-827x(02)01217-x |
2002 |
* |
| Pathogenicity |
Bacteriologic evaluation of the effect of Nd:YAG laser irradiation in experimental infected root canals. |
Piccolomini R, D'Arcangelo C, D'Ercole S, Catamo G, Schiaffino G, De Fazio P |
J Endod |
10.1097/00004770-200204000-00004 |
2002 |
* |
| Pathogenicity |
[In vitro antimicrobial activity of glutaraldehyde plus O-phenylphenol association (ratio 2:1)]. |
D'Ercole S, Catamo G, De Fazio P, Piccolomini R |
Minerva Stomatol |
|
2002 |
* |
| Metabolism |
Differential involvement of reactive oxygen species and myeloperoxidase in oxygen-dependent killing of urinary tract bacterial isolates by polymorphonuclear leukocytes. |
Oh-oka H, Fujisawa M, Okada H, Arakawa S, Kamidono S |
Urol Res |
10.1007/s002400100217 |
2001 |
* |
| Pathogenicity |
Reproducibility of control organism zone diameters for batches of IsoSensitest agar manufactured from 1996 to 2000 using the BSAC disc susceptibility test method. |
Landrygan J, James PA, Brooks D, Kubiak EM |
J Antimicrob Chemother |
10.1093/jac/49.2.391 |
2002 |
* |
| Pathogenicity |
[Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro]. |
Xu Z, Liu F, Wang X |
Zhonghua Jie He He Hu Xi Za Zhi |
|
2001 |
* |
| Pathogenicity |
Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains. |
Biedenbach DJ, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(01)00294-2 |
2001 |
* |
| Pathogenicity |
Two methods to evaluate the antimicrobial action of calcium hydroxide paste. |
Estrela C, Rodrigues de Araujo Estrela C, Bammann LL, Pecora JD |
J Endod |
10.1097/00004770-200112000-00002 |
2001 |
* |
| Pathogenicity |
Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis. |
Yanyali A, Cetin S, Talu H, Vahaboglu H |
Ophthalmologica |
10.1159/000050905 |
2001 |
* |
| Pathogenicity |
Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program. |
Jones RN |
Arch Pathol Lab Med |
10.5858/2001-125-1285-MPATAO |
2001 |
* |
| Pathogenicity |
Effect of serum from different patient populations on the serum bactericidal test. |
Kays MB, White RL, Friedrich LV |
J Antimicrob Chemother |
10.1093/jac/48.3.417 |
2001 |
* |
| Metabolism |
Biosynthesis and structural characterization of medium-chain-length poly(3-hydroxyalkanoates) produced by Pseudomonas aeruginosa from fatty acids. |
Ballistreri A, Giuffrida M, Guglielmino SP, Carnazza S, Ferreri A, Impallomeni G |
Int J Biol Macromol |
10.1016/s0141-8130(01)00154-4 |
2001 |
* |
| Pathogenicity |
Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities. |
Kucukbay H, Durmaz R, Guven M, Gunal S |
Arzneimittelforschung |
10.1055/s-0031-1300057 |
2001 |
* |
| Cultivation |
Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa. |
Hennard C, Truong QC, Desnottes JF, Paris JM, Moreau NJ, Abdallah MA |
J Med Chem |
10.1021/jm990508g |
2001 |
* |
| Enzymology |
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model. |
Robaux MA, Dube L, Caillon J, Bugnon D, Kergueris MF, Navas D, Le Conte P, Baron D, Potel G |
J Antimicrob Chemother |
10.1093/jac/47.5.617 |
2001 |
* |
| Pathogenicity |
Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. |
Dominguez MC, de La Rosa M, Borobio MV |
J Antimicrob Chemother |
10.1093/jac/47.4.391 |
2001 |
* |
| Pathogenicity |
Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal. |
Estrela C, Bammann LL, Estrela CR, Silva RS, Pecora JD |
Braz Dent J |
|
2000 |
* |
| Pathogenicity |
In vitro evaluation of antimicrobial activity of sealers and pastes used in endodontics. |
Leonardo MR, da Silva LA, Tanomaru Filho M, Bonifacio KC, Ito IY |
J Endod |
10.1097/00004770-200007000-00003 |
2000 |
* |
| Pathogenicity |
[Antibacterial activity of histidine-rich polypeptides in human parotid saliva]. |
Wu Q, Yang M, Zhong D |
Zhonghua Kou Qiang Yi Xue Za Zhi |
|
1997 |
* |
| Pathogenicity |
Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. |
Todisco T, Eslami A, Baglioni S, Sposini T, Tascini C, Sommer E, Knoch M |
J Aerosol Med |
10.1089/jam.2000.13.11 |
2000 |
* |
| Phylogeny |
Antimicrobial properties of copper-coated electroconductive polyester fibers. |
Grzybowski J, Trafny EA |
Polim Med |
|
1999 |
* |
| Enzymology |
[Inter-laboratory reproducibility of pulsed-field electrophoresis for the study of 12 types of Pseudomonas aeruginosa]. |
Foissaud V, Puyhardy JM, Chapalain JC, Salord H, Depina JJ, Morillon M, Nicolas P, Perrier-Gros-Claude JD |
Pathol Biol (Paris) |
|
1999 |
* |
| Pathogenicity |
Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications. |
Odland BA, Erwin ME, Jones RN |
J Clin Microbiol |
10.1128/JCM.38.1.453-455.2000 |
2000 |
* |
| Pathogenicity |
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. |
Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G |
J Antimicrob Chemother |
10.1093/jac/44.5.641 |
1999 |
* |
| Pathogenicity |
Reduction of the bacterial load by the silver-coated endotracheal tube (SCET), a laboratory investigation. |
Hartmann M, Guttmann J, Muller B, Hallmann T, Geiger K |
Technol Health Care |
|
1999 |
* |
| Pathogenicity |
Decontamination of human sclera: an in vitro study. |
Lucci LM, Yu MC, Hofling-Lima AL |
Cornea |
00003226-199909000-00011 |
1999 |
* |
| Enzymology |
The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas aeruginosa. |
Lo HH, Hsieh SE, Tsai KJ, Chung JG |
Drug Chem Toxicol |
10.3109/01480549909042532 |
1999 |
* |
| Pathogenicity |
Antibacterial and antifungal activities of complexes of ruthenium (II). |
Cetinkaya B, Ozdemir I, Binbasioglu B, Durmaz R, Gunal S |
Arzneimittelforschung |
10.1055/s-0031-1300457 |
1999 |
* |
| Pathogenicity |
New cytokine dressings. II. Stimulation of oxidative burst in leucocytes in vitro and reduction of viable bacteria within an infected wound. |
Grzybowski J, Janiak MK, Oldak E, Lasocki K, Wrembel-Wargocka J, Cheda A, Antos-Bielska M, Pojda Z |
Int J Pharm |
10.1016/s0378-5173(99)00064-2 |
1999 |
* |
| Metabolism |
Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa. |
Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, Cornelis P |
J Bacteriol |
10.1128/JB.181.12.3849-3851.1999 |
1999 |
* |
| Pathogenicity |
In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. |
Schwab U, Gilligan P, Jaynes J, Henke D |
Antimicrob Agents Chemother |
10.1128/AAC.43.6.1435 |
1999 |
* |
| Pathogenicity |
New derivatives of benzimidazole and their antimicrobial activity. |
Cetinkaya E, Alici B, Gok Y, Durmaz R, Gunal S |
J Chemother |
10.1179/joc.1999.11.2.83 |
1999 |
* |
| Pathogenicity |
The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. |
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A |
J Clin Microbiol |
10.1128/JCM.37.6.1771-1776.1999 |
1999 |
* |
| Pathogenicity |
Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. |
Kamberi M, Tsutsumi K, Kotegawa T, Kawano K, Nakamura K, Niki Y, Nakano S |
Antimicrob Agents Chemother |
10.1128/AAC.43.3.525 |
1999 |
* |
| Pathogenicity |
In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group. |
Jones RN, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(98)00063-7 |
1998 |
* |
| Metabolism |
The effect of sulindac on arylamine N-acetyltransferase activity in Pseudomonas aeruginosa. |
Lo HH, Hsieh SE, Chung JG |
Microbios |
|
1998 |
* |
| Metabolism |
The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway. |
Kinzel O, Tappe R, Gerus I, Budzikiewicz H |
J Antibiot (Tokyo) |
10.7164/antibiotics.51.499 |
1998 |
* |
| Pathogenicity |
Application of X-ray micrography and imaging to study the effect of gentamicin on Pseudomonas aeruginosa. |
Rajyaguru JM, Torres DS, Abel E, Richardson MC, Muszynski MJ |
J Antimicrob Chemother |
10.1093/jac/41.5.557 |
1998 |
* |
| Pathogenicity |
Changes in MIC alter responses of Pseudomonas aeruginosa to tobramycin exposure. |
Ioannides-Demos LL, Liolios L, Wood P, Spicer WJ, McLean AJ |
Antimicrob Agents Chemother |
10.1128/AAC.42.6.1365 |
1998 |
* |
| Pathogenicity |
Antibacterial activity of rhodium, iridium, and ruthenium tripodal phosphine complexes. |
Sulu M, Kucukbay H, Durmaz R, Gunal S |
Arzneimittelforschung |
|
1998 |
* |
| Pathogenicity |
Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa. |
Carmeli Y, Eichelberger K, Soja D, Dakos J, Venkataraman L, DeGirolami P, Samore M |
J Clin Microbiol |
10.1128/JCM.36.2.595-597.1998 |
1998 |
* |
| Pathogenicity |
Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. |
Nakano M, Deguchi T, Kawamura T, Yasuda M, Kimura M, Okano Y, Kawada Y |
Antimicrob Agents Chemother |
10.1128/AAC.41.10.2289 |
1997 |
* |
| Pathogenicity |
Nebulization and anti-Pseudomonas aeruginosa activity of colistin. |
Diot P, Gagnadoux F, Martin C, Ellataoui H, Furet Y, Breteau M, Boissinot E, Lemarie E |
Eur Respir J |
10.1183/09031936.97.10091995 |
1997 |
* |
| Pathogenicity |
Synthesis and antimicrobial activities of 2-[(alpha-methylbenzylidene)-hydrazino]benzoxazoles. |
Ersan S, Nacak S, Berkem R, Ozden T |
Arzneimittelforschung |
|
1997 |
* |
| Pathogenicity |
Susceptibility testing quality control studies with fosfomycin tromethamine. |
Fuchs PC, Barry AL, Brown SD |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01708240 |
1997 |
* |
| Pathogenicity |
Does tea tree oil have a place in the topical treatment of burns? |
Faoagali J, George N, Leditschke JF |
Burns |
10.1016/s0305-4179(96)00130-1 |
1997 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of 1-dialkylaminomethyl- 2-(p-substituted phenyl)-5-substituted benzimidazole derivatives. |
Ersan S, Nacak S, Acar N, Noyanalpan N |
Arzneimittelforschung |
|
1997 |
* |
| Pathogenicity |
Synthesis and antimicrobial evaluation of indole containing derivatives of 1,3,4-thiadiazole, 1,2,4-triazole and their open-chain counterparts. |
Tsotinis A, Varvaresou A, Calogeropoulou T, Siatra-Papastaikoudi T, Tiligada A |
Arzneimittelforschung |
|
1997 |
* |
| Pathogenicity |
The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin. |
Nwariaku FE, McIntyre KL, Sikes PJ, Mileski WJ |
J Antimicrob Chemother |
10.1093/jac/39.2.265 |
1997 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of electron rich olefin derived cyclic ureas. |
Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R |
Arzneimittelforschung |
|
1996 |
* |
| Pathogenicity |
Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. |
Shafer WM, Hubalek F, Huang M, Pohl J |
Infect Immun |
10.1128/iai.64.11.4842-4845.1996 |
1996 |
* |
| Enzymology |
In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man. |
Jokelainen K, Siitonen A, Jousimies-Somer H, Nosova T, Heine R, Salaspuro M |
Alcohol Clin Exp Res |
10.1111/j.1530-0277.1996.tb01932.x |
1996 |
* |
| Pathogenicity |
Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II). |
Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R |
Arzneimittelforschung |
|
1996 |
* |
| Pathogenicity |
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. |
White RL, Burgess DS, Manduru M, Bosso JA |
Antimicrob Agents Chemother |
10.1128/AAC.40.8.1914 |
1996 |
* |
| Pathogenicity |
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. |
Marshall SA, Jones RN, Wanger A, Washington JA, Doern GV, Leber AL, Haugen TH |
J Clin Microbiol |
10.1128/jcm.34.8.2027-2029.1996 |
1996 |
* |
| Enzymology |
Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing. |
Wood PJ, Ioannides-Demos LL, Bastone EB, Spicer WJ, McLean AJ |
Antimicrob Agents Chemother |
10.1128/AAC.40.5.1321 |
1996 |
* |
| Enzymology |
Physical mapping of several heat-shock genes in Pseudomonas aeruginosa and the cloning of the mopA (GroEL) gene. |
Farinha MA, Mockett R, Went CJ, Jardine S, Naczynski LM, Kropinski AM |
Can J Microbiol |
10.1139/m96-048 |
1996 |
* |
| Enzymology |
A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa. |
Madaras-Kelly KJ, Larsson AJ, Rotschafer JC |
J Antimicrob Chemother |
10.1093/jac/37.4.703 |
1996 |
* |
| Pathogenicity |
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. |
Cappelletty DM, Rybak MJ |
Antimicrob Agents Chemother |
10.1128/AAC.40.3.677 |
1996 |
* |
| Pathogenicity |
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. |
O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM |
Invest Ophthalmol Vis Sci |
|
1996 |
* |
| Pathogenicity |
Synthesis of ethanone derived from 2-benzoxazolinones and their antimicrobial activities. |
Erol DD, Calis U, Yulug N |
Arzneimittelforschung |
|
1996 |
* |
| Pathogenicity |
Synthesis and antimicrobial activity of substituted benzimidazole, benzothiazole and imidazole derivatives. |
Kucukbay H, Cetinkaya E, Durmaz R |
Arzneimittelforschung |
|
1995 |
* |
| Enzymology |
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model. |
Cappelletty DM, Kang SL, Palmer SM, Rybak MJ |
Antimicrob Agents Chemother |
10.1128/AAC.39.8.1797 |
1995 |
* |
| Metabolism |
Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. |
Brown ML, Aldrich HC, Gauthier JJ |
Appl Environ Microbiol |
10.1128/aem.61.1.187-193.1995 |
1995 |
* |
| Phylogeny |
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628. |
Barry AL, Fuchs PC, Allen SD, Tenover FC, Jorgensen JH, Reller LB |
J Clin Microbiol |
10.1128/jcm.33.1.235-238.1995 |
1995 |
* |
| Enzymology |
Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro. |
Barclay ML, Begg EJ, Chambers ST, Boswell DR |
Antimicrob Agents Chemother |
10.1128/AAC.39.1.132 |
1995 |
* |
| Pathogenicity |
Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin. |
Barry A, Fuchs P, Tenover F, Allen S, Hardy D, Jorgensen J, McLaughlin J, Reller L |
Eur J Clin Microbiol Infect Dis |
10.1007/BF02111343 |
1994 |
* |
| Pathogenicity |
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. |
Strayer AH, Gilbert DH, Pivarnik P, Medeiros AA, Zinner SH, Dudley MN |
Antimicrob Agents Chemother |
10.1128/AAC.38.10.2351 |
1994 |
* |
| Pathogenicity |
[The synergistic action of quaternary ammonium derivatives and inhibitors of nitrate reduction in respect to Pseudomonas aeruginosa]. |
Vievskii AN |
Mikrobiol Z |
|
1994 |
* |
| Pathogenicity |
In vitro antibacterial activity of sucralfate. |
Bergmans D, Bonten M, Gaillard C, van Tiel F, van der Geest S, Stobberingh E |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01971318 |
1994 |
* |
| Cultivation |
Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. |
Karlowsky JA, Zhanel GG, Davidson RJ, Hoban DJ |
J Antimicrob Chemother |
10.1093/jac/33.5.937 |
1994 |
* |
| Pathogenicity |
Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. |
Mouton JW, den Hollander JG |
Antimicrob Agents Chemother |
10.1128/AAC.38.5.931 |
1994 |
* |
| Pathogenicity |
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. |
Bale MJ, Jones RN, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(94)90054-x |
1994 |
* |
| Pathogenicity |
Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: comparison of several agar media. |
Traub WH, Leonhard B |
Chemotherapy |
10.1159/000239296 |
1994 |
* |
| Pathogenicity |
The effectiveness of gentamicin or polymyxin B for the control of bacterial growth in equine semen stored at 20 degrees C or 5 degrees C for up to forty-eight hours. |
Vaillancourt D, Guay P, Higgins R |
Can J Vet Res |
|
1993 |
* |
| Pathogenicity |
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group. |
Bale MJ, Jones RN |
J Clin Microbiol |
10.1128/jcm.31.9.2538-2540.1993 |
1993 |
* |
| Enzymology |
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model. |
McGrath BJ, Lamp KC, Rybak MJ |
Antimicrob Agents Chemother |
10.1128/AAC.37.9.1931 |
1993 |
* |
| Metabolism |
Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen. |
Hobden JA, Hill JM, Engel LS, O'Callaghan RJ |
Antimicrob Agents Chemother |
10.1128/AAC.37.9.1856 |
1993 |
* |
| Pathogenicity |
Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity. |
Shafer WM, Shepherd ME, Boltin B, Wells L, Pohl J |
Infect Immun |
10.1128/iai.61.5.1900-1908.1993 |
1993 |
* |
| Pathogenicity |
Efficacy of various surface disinfectants on an irregular surface. |
Lado EA, Anekal S, Stout FW |
Oral Surg Oral Med Oral Pathol |
10.1016/0030-4220(93)90167-3 |
1993 |
* |
| Enzymology |
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. |
McGrath BJ, Bailey EM, Lamp KC, Rybak MJ |
Antimicrob Agents Chemother |
10.1128/AAC.36.12.2741 |
1992 |
* |
| Pathogenicity |
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. |
Barclay ML, Begg EJ, Chambers ST |
Antimicrob Agents Chemother |
10.1128/AAC.36.9.1951 |
1992 |
* |
| Pathogenicity |
Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities. |
Gunes HS, Cosar G |
Arzneimittelforschung |
|
1992 |
* |
| Pathogenicity |
Synthesis and evaluation of antimicrobial activity of new 4-nitroso and 4-diazopyrazole derivatives. |
Daidone G, Plescia S, Raffa D, Maggio B, Schillaci D |
Farmaco |
|
1992 |
* |
| Enzymology |
Ability of National Committee for Clinical Laboratory Standards-recommended quality control strains from the American Type Culture Collection to detect errors in disk diffusion susceptibility tests. |
Yechouron A, Dascal A, Stevenson J, Mendelson J |
J Clin Microbiol |
10.1128/jcm.29.12.2758-2762.1991 |
1991 |
* |
| Pathogenicity |
In vitro phagocytic interaction between Trichomonas vaginalis isolates and bacteria. |
Juliano C, Cappuccinelli P, Mattana A |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01963936 |
1991 |
* |
| Pathogenicity |
[Time-killing curves of Pseudomonas aeruginosa strains exposed to polymyxin B]. |
Peyret M, Flandrois JP, Fardel G |
Pathol Biol (Paris) |
|
1991 |
* |
| Pathogenicity |
Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa. |
Park MK, Muhvich KH, Myers RA, Marzella L |
Antimicrob Agents Chemother |
10.1128/AAC.35.4.691 |
1991 |
* |
| Pathogenicity |
Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. |
White RL, Kays MB, Friedrich LV, Brown EW, Koonce JR |
J Clin Microbiol |
10.1128/jcm.29.2.398-400.1991 |
1991 |
* |
| Metabolism |
Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. |
Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM |
Invest Ophthalmol Vis Sci |
|
1990 |
* |
| Metabolism |
Nitrosoguanidine-induced adaptive repair in Pseudomonas aeruginosa. |
Rasool SA, Mirza A, Khan MA |
Curr Genet |
10.1007/BF00334521 |
1990 |
* |
| Enzymology |
Glutathione transferase in bacteria: subunit composition and antigenic characterization. |
Piccolomini R, Di Ilio C, Aceto A, Allocati N, Faraone A, Cellini L, Ravagnan G, Federici G |
J Gen Microbiol |
10.1099/00221287-135-11-3119 |
1989 |
* |
| Metabolism |
Evidence for different pyoverdine-mediated iron uptake systems among Pseudomonas aeruginosa strains. |
Cornelis P, Hohnadel D, Meyer JM |
Infect Immun |
10.1128/iai.57.11.3491-3497.1989 |
1989 |
* |
| Pathogenicity |
Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures. |
Staneck JL, Glenn S, DiPersio JR, Leist PA |
J Clin Microbiol |
10.1128/jcm.27.10.2277-2285.1989 |
1989 |
* |
| Pathogenicity |
Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay. |
Pitkin DH, Sheikh W, Nadler H |
J Antimicrob Chemother |
10.1093/jac/24.suppl_a.251 |
1989 |
* |
| Pathogenicity |
Synthesis and biological activity of 6-acyl-3-substituted-2(3H)-benzoxazolones. |
Erol DD, Erdogan H, Yulug N |
J Pharm Belg |
|
1989 |
* |
| Pathogenicity |
Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa. |
Muhvich KH, Park MK, Myers RA, Marzella L |
Antimicrob Agents Chemother |
10.1128/AAC.33.9.1526 |
1989 |
* |
| Pathogenicity |
Synthesis of some new Mannich bases derived from 6-acyl-3-(3,5-dimethylpiperidinomethyl)-2(3H)-benzoxazolones+ ++ and their biological activities. |
Erol DD, Rosen A, Erdogan H, Yulug N |
Arzneimittelforschung |
|
1989 |
* |
| Pathogenicity |
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria. |
Fuchs PC, Jones RN, Barry AL, Gavan TL |
J Clin Microbiol |
10.1128/jcm.27.1.49-52.1989 |
1989 |
* |
| Cultivation |
Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin. |
Hohl P, Felber AM |
J Antimicrob Chemother |
10.1093/jac/22.supplement_d.71 |
1988 |
* |
| Pathogenicity |
[Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram]. |
Buisson Y, Bercion R, Mauclere P, Hugard L, Schill H |
Pathol Biol (Paris) |
|
1988 |
* |
| Pathogenicity |
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control. |
Jones RN, Barry AL, Pfaller M, Allen SD, Ayers LW, Fuchs PC |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(88)90063-6 |
1988 |
* |
| Pathogenicity |
Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood. |
Traub WH, Spohr M, Bauer D |
Chemotherapy |
10.1159/000238582 |
1988 |
* |
| Cultivation |
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods. |
Jones RN, Barry AL |
J Clin Microbiol |
10.1128/jcm.25.11.2243-2246.1987 |
1987 |
* |
| Pathogenicity |
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin. |
Jones RN, Barry AL |
J Clin Microbiol |
10.1128/jcm.25.11.2211-2213.1987 |
1987 |
* |
| Metabolism |
Lectin-mediated bacterial adhesion to human tissue. |
Beuth J, Ko HL, Uhlenbruck G, Pulverer G |
Eur J Clin Microbiol |
10.1007/BF02014258 |
1987 |
* |
| Pathogenicity |
In vitro and in vivo inhibition of lectin mediated adhesion of Pseudomonas aeruginosa by receptor blocking carbohydrates. |
Ko HL, Beuth J, Solter J, Schroten H, Uhlenbruck G, Pulverer G |
Infection |
10.1007/BF01644121 |
1987 |
* |
| Pathogenicity |
Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa. |
Aronoff SC, Shlaes DM |
J Infect Dis |
10.1093/infdis/155.5.936 |
1987 |
* |
| Pathogenicity |
Quality control limits for microdilution susceptibility tests with norfloxacin. |
Barry AL, Gavan TL, Ayers LW, Fuchs PC, Gerlach EH, Thornsberry C |
J Clin Microbiol |
10.1128/jcm.25.1.165-166.1987 |
1987 |
* |
| Pathogenicity |
In-vitro emergence of beta-lactam-resistant variants of Pseudomonas aeruginosa. |
Eng RH, Smith SM, Cherubin CE |
J Antimicrob Chemother |
10.1093/jac/17.6.717 |
1986 |
* |
| Pathogenicity |
Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray. |
Staneck JL |
J Clin Microbiol |
10.1128/jcm.23.6.1134-1135.1986 |
1986 |
* |
| Metabolism |
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. |
Barry AL, Thornsberry C, Jones RN, Gavan TL |
Rev Infect Dis |
10.1093/clinids/7.supplement_4.s594 |
1985 |
* |
| Pathogenicity |
Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C. |
Turgeon PL, Desrochers C |
Antimicrob Agents Chemother |
10.1128/AAC.28.5.711 |
1985 |
* |
| Enzymology |
Investigations on the bactericidal activity of fosfomycin using the membrane filter-agar dilution method and the time-kill technique. |
Haag R, Hoffmann R |
Zentralbl Bakteriol Mikrobiol Hyg A |
10.1016/s0176-6724(85)80123-1 |
1985 |
* |
| Pathogenicity |
[Comparative evaluation of 2 methods--dilution in agar and diffusion in agar--in determining Pseudomonas aeruginosa sensitivity to antibiotics]. |
Gabrielian SA, Bogdanova LF, Vorob'eva LS, Givental' NI |
Antibiot Med Biotekhnol |
|
1985 |
* |
| Pathogenicity |
Antimicrobial activity of bupivacaine and morphine. |
Rosenberg PH, Renkonen OV |
Anesthesiology |
10.1097/00000542-198502000-00015 |
1985 |
* |
| Pathogenicity |
Computer-controlled in-vitro simulation of multiple dosing regimens. |
Ledergerber B, Blaser J, Luthy R |
J Antimicrob Chemother |
10.1093/jac/15.suppl_a.169 |
1985 |
* |
| Pathogenicity |
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks. |
Barry AL, Thornsberry C, Gavan TL, Jones RN |
J Clin Microbiol |
10.1128/jcm.20.5.988-989.1984 |
1984 |
* |
| Pathogenicity |
Bactericidal activity of antimicrobial drugs in simulated urine specimens at various temperatures of incubation. |
Traub WH, Spohr M, Arnold M, Klotz M |
Zentralbl Bakteriol Mikrobiol Hyg A |
|
1983 |
* |
| Pathogenicity |
Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines. |
Jones RN, Barry AL, Thornsberry C |
J Clin Microbiol |
10.1128/jcm.18.1.211-214.1983 |
1983 |
* |
| Pathogenicity |
Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing. |
Kronvall G |
J Clin Microbiol |
10.1128/jcm.17.6.975-980.1983 |
1983 |
* |
| Pathogenicity |
Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure. |
Grimm H |
Infection |
10.1007/BF01641104 |
1983 |
* |
| Pathogenicity |
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. |
Tenney JH, Maack RW, Chippendale GR |
Antimicrob Agents Chemother |
10.1128/AAC.23.1.188 |
1983 |
* |
| Pathogenicity |
Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing. |
Kronvall G |
J Clin Microbiol |
10.1128/jcm.16.5.784-793.1982 |
1982 |
* |
| Enzymology |
Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. |
Gerber AU, Vastola AP, Brandel J, Craig WA |
J Infect Dis |
10.1093/infdis/146.5.691 |
1982 |
* |
| Enzymology |
[Studies on bacteriologic contamination of potassium chloride solution 25% in multidose containers regularly used on hospital wards]. |
Schramm G, Bianchi S |
Schweiz Med Wochenschr |
|
1982 |
* |
| Pathogenicity |
Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test. |
Fass RJ |
Antimicrob Agents Chemother |
10.1128/AAC.22.1.28 |
1982 |
* |
| Pathogenicity |
Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks. |
Barry AL, Jones RN, Thornsberry C, Gavan TL |
J Clin Microbiol |
10.1128/jcm.16.1.135-140.1982 |
1982 |
* |
| Cultivation |
Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin. |
Casillas E, Kenny MA, Minshew BH, Schoenknecht FD |
Antimicrob Agents Chemother |
10.1128/AAC.19.6.987 |
1981 |
* |
| Pathogenicity |
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. |
Reimer LG, Stratton CW, Reller LB |
Antimicrob Agents Chemother |
10.1128/AAC.19.6.1050 |
1981 |
* |
| Pathogenicity |
Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. |
Woolfrey BF, Fox JM, Quall CO |
Am J Clin Pathol |
10.1093/ajcp/75.1.39 |
1981 |
* |
| Pathogenicity |
Anomalous effect of serum on the antimicrobial activity of cefoperazone. |
Lang SD, Cameron GL, Mullins PR |
Drugs |
10.2165/00003495-198100221-00012 |
1981 |
* |
| Pathogenicity |
Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. |
Fass RJ, Barnishan J |
Antimicrob Agents Chemother |
10.1128/AAC.16.5.622 |
1979 |
* |
| Pathogenicity |
Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test. |
Woolfrey BF, Ramadei WA, Quall CO |
Am J Clin Pathol |
10.1093/ajcp/72.5.861 |
1979 |
* |
| Pathogenicity |
Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study. |
Washington JA 2nd, Yu PK, Gavan TL, Schoenknecht FD, Thornsberry C |
Antimicrob Agents Chemother |
10.1128/AAC.15.3.400 |
1979 |
* |
| Pathogenicity |
Standardization of direct susceptibility test for blood cultures. |
Fay D, Oldfather JE |
J Clin Microbiol |
10.1128/jcm.9.3.347-350.1979 |
1979 |
* |
| Pathogenicity |
Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study. |
Prior RB, Fass RJ |
Antimicrob Agents Chemother |
10.1128/AAC.14.3.507 |
1978 |
* |
| Pathogenicity |
Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. |
Pollock HM, Minshew BH, Kenny MA, Schoenknecht FD |
Antimicrob Agents Chemother |
10.1128/AAC.14.3.360 |
1978 |
* |
| Phylogeny |
In Silico Study for Algerian Essential Oils as Antimicrobial Agents against Multidrug-Resistant Bacteria Isolated from Pus Samples. |
Aouf A, Bouaouina S, Abdelgawad MA, Abourehab MAS, Farouk A |
Antibiotics (Basel) |
10.3390/antibiotics11101317 |
2022 |
* |
| Enzymology |
3D Printed Microfluidic Bioreactors Used for the Preferential Growth of Bacterial Biofilms through Dielectrophoresis. |
Csapai A, Toc DA, Popa F, Tosa N, Pascalau V, Costache C, Botan A, Popa CO |
Micromachines (Basel) |
10.3390/mi13091377 |
2022 |
* |
| Biotechnology |
Green Production and Interaction of Carboxylated CNTs/Biogenic ZnO Composite for Antibacterial Activity. |
Hussain S, Khakwani N, Faiz Y, Zulfiqar S, Shafiq Z, Faiz F, Elhakem A, Sami R, Aljuraide NI, Farid T, Aljabri MD, Rahman MM |
Bioengineering (Basel) |
10.3390/bioengineering9090437 |
2022 |
* |
| Proteome |
Biofilm matrix proteome of clinical strain of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unit. |
Egorova DA, Solovyev AI, Polyakov NB, Danilova KV, Scherbakova AA, Kravtsov IN, Dmitrieva MA, Rykova VS, Tutykhina IL, Romanova YM, Gintsburg AL |
Microb Pathog |
10.1016/j.micpath.2022.105714 |
2022 |
* |
| Pathogenicity |
Generation of a recombinant antibody for sensitive detection of Pseudomonas aeruginosa. |
Lim GM, Kim JK, Kim EJ, Lee CS, Kim W, Kim BG, Jeong HJ |
BMC Biotechnol |
10.1186/s12896-022-00751-9 |
2022 |
* |
| Pathogenicity |
Biofabrication of ZnO/Malachite nanocomposite and its coating with chitosan to heal infectious wounds. |
Rajabloo Z, Farahpour MR, Saffarian P, Jafarirad S |
Sci Rep |
10.1038/s41598-022-15768-5 |
2022 |
* |
| Metabolism |
Mutations of gammaCOP Gene Disturb Drosophila melanogaster Innate Immune Response to Pseudomonas aeruginosa. |
Chifiriuc MC, Bologa AM, Ratiu AC, Ionascu A, Ecovoiu AA |
Int J Mol Sci |
10.3390/ijms23126499 |
2022 |
* |
|
Antimicrobial Potential of Conjugated Lignin/Morin/Chitosan Combinations as a Function of System Complexity. |
Yaneva Z, Beev G, Rusenova N, Ivanova D, Tzanova M, Stoeva D, Toneva M |
Antibiotics (Basel) |
10.3390/antibiotics11050650 |
2022 |
* |
|
Antibiofilm and cytotoxic potential of extracellular biosynthesized gold nanoparticles using actinobacteria Amycolatopsis sp. KMN. |
Kabiri F, Aghaei SS, Pourbabaee AA, Soleimani M, Komeili Movahhed T |
Prep Biochem Biotechnol |
10.1080/10826068.2022.2076244 |
2022 |
* |
|
The antimicrobial effect of calcium-doped titanium is activated by fibrinogen adsorption. |
Cao H, Dauben TJ, Helbing C, Jia Z, Zhang Y, Huang M, Muller L, Gu S, Zhang X, Qin H, Martin K, Bossert J, Jandt KD |
Mater Horiz |
10.1039/d1mh02009a |
2022 |
* |
|
Promising Endophytic Alternaria alternata from Leaves of Ziziphus spina-christi: Phytochemical Analyses, Antimicrobial and Antioxidant Activities. |
Elghaffar RYA, Amin BH, Hashem AH, Sehim AE |
Appl Biochem Biotechnol |
10.1007/s12010-022-03959-9 |
2022 |
* |
|
Assessment of bacteriophage-encoded endolysin as a potent antimicrobial agent against antibiotic-resistant Salmonella Typhimurium. |
Kim J, Kim JC, Ahn J |
Microb Pathog |
10.1016/j.micpath.2022.105576 |
2022 |
* |
|
Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa. |
Su YB, Tang XK, Zhu LP, Yang KX, Pan L, Li H, Chen ZG |
Front Microbiol |
10.3389/fmicb.2022.845173 |
2022 |
* |
|
Template synthesis, DNA binding, antimicrobial activity, Hirshfeld surface analysis, and 1D helical supramolecular structure of a novel binuclear copper(ii) Schiff base complex. |
Goudarziafshar H, Yousefi S, Abbasi Tyula Y, Dusek M, Eigner V |
RSC Adv |
10.1039/d2ra00719c |
2022 |
* |
|
Biofilm Growth on Simulated Fracture Fixation Plates Using a Customized CDC Biofilm Reactor for a Sheep Model of Biofilm-Related Infection. |
Kay W, Hunt C, Nehring L, Barnum B, Ashton N, Williams D |
Microorganisms |
10.3390/microorganisms10040759 |
2022 |
* |
|
Conglomeratin: a new antibacterial flavonol derivative from Macaranga conglomerata Brenan (Euphorbiaceae). |
Hashim I, Onyari JM, Omosa LK, Maru SM, Nchiozem-Ngnitedem VA, Karpoormath R |
Nat Prod Res |
10.1080/14786419.2022.2061481 |
2022 |
* |
|
Coordination complexes constructed from pyrazole-acetamide and pyrazole-quinoxaline: effect of hydrogen bonding on the self-assembly process and antibacterial activity. |
Chkirate K, Karrouchi K, Chakchak H, Mague JT, Radi S, Adarsh NN, Li W, Talbaoui A, Essassi EM, Garcia Y |
RSC Adv |
10.1039/d1ra09027e |
2022 |
* |
|
Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria. |
Xie YP, Sangaraiah N, Meng JP, Zhou CH |
J Med Chem |
10.1021/acs.jmedchem.2c00001 |
2022 |
* |
|
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing. |
Matuschek E, Longshaw C, Takemura M, Yamano Y, Kahlmeter G |
J Antimicrob Chemother |
10.1093/jac/dkac080 |
2022 |
* |
|
Anthraquinones from the Aerial Parts of Rubia cordifolia with Their NO Inhibitory and Antibacterial Activities. |
Luo H, Qin W, Zhang H, Ren FC, Fang WT, Kong QH, Yang L, Zhang JM, Fang CW, Hu JM, Liu SJ |
Molecules |
10.3390/molecules27051730 |
2022 |
* |
|
Sustainable Antibacterial and Antiviral High-Performance Copper-Coated Filter Produced via Ion Beam Treatment. |
Jung S, Yang JY, Jang D, Kim T, Baek KH, Yoon H, Park JY, Kim SK, Hong J, Ryoo S, Jang HW, Lee S |
Polymers (Basel) |
10.3390/polym14051007 |
2022 |
* |
|
Antimicrobial activity of supramolecular salts of gallium(III) and proflavine and the intriguing case of a trioxalate complex. |
Guerrini M, d'Agostino S, Grepioni F, Braga D, Lekhan A, Turner RJ |
Sci Rep |
10.1038/s41598-022-07813-0 |
2022 |
* |
|
Gallium-Curcumin Nanoparticle Conjugates as an Antibacterial Agent against Pseudomonas aeruginosa: Synthesis and Characterization. |
Ramesh G, Kaviyil JE, Paul W, Sasi R, Joseph R |
ACS Omega |
10.1021/acsomega.1c06398 |
2022 |
* |
|
Design, Characterization, and Antimicrobial Evaluation of Copper Nanoparticles Utilizing Tamarixinin a Ellagitannin from Galls of Tamarix aphylla. |
Orabi MAA, Salem-Bekhit MM, Taha EI, Abdel-Sattar ES, Alqahtani OS, Al-Joufi FA, Abdel-Wahab BA, Alshabi AM, Alyami HS, Ahmad J, Hatano T |
Pharmaceuticals (Basel) |
10.3390/ph15020216 |
2022 |
* |
|
Antimicrobial activities of fungus comb extracts isolated from Indomalayan termite (Macrotermes gilvus Hagen) mound. |
Witasari LD, Wahyu KW, Anugrahani BJ, Kurniawan DC, Haryanto A, Nandika D, Karlinasari L, Arinana A, Batubara I, Santoso D, Rachmayanti Y, Firmansyah D, Sudiana IK, Hertanto DM |
AMB Express |
10.1186/s13568-022-01359-0 |
2022 |
* |
|
Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections. |
Agarwal A, Singh P, Maurya A, Patel UK, Singh A, Nath G |
ACS Omega |
10.1021/acsomega.1c05303 |
2022 |
* |
|
Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa. |
Yuan Y, Rosado-Lugo JD, Zhang Y, Datta P, Sun Y, Cao Y, Banerjee A, Parhi AK |
Antibiotics (Basel) |
10.3390/antibiotics11010030 |
2021 |
* |
|
Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories. |
Cao M, Huang L, Hu Y, Fang Y, Zhang R, Chen G |
Front Microbiol |
10.3389/fmicb.2021.765757 |
2021 |
* |
|
A Systematic Study of the Antibacterial Activity of Basidiomycota Crude Extracts. |
Clericuzio M, Bivona M, Gamalero E, Bona E, Novello G, Massa N, Dovana F, Marengo E, Robotti E |
Antibiotics (Basel) |
10.3390/antibiotics10111424 |
2021 |
* |
|
Silver nanoparticles from residual biomass: Biosynthesis, characterization and antimicrobial activity. |
Muraro PCL, Pinheiro LDSM, Chuy G, Vizzotto BS, Pavoski G, Espinosa DCR, Rech VC, da Silva WL |
J Biotechnol |
10.1016/j.jbiotec.2021.11.003 |
2021 |
* |
|
Eco-friendly intracellular biosynthesis of CdS quantum dots using Pseudomonas aeruginosa: Evaluation of antimicrobial effects and DNA cleavage activities. |
Ocal N, Ceylan A, Duman F |
Recent Pat Nanotechnol |
10.2174/1872210515666210719122353 |
2021 |
* |
|
Mesoporous Silica and Titania-Based Materials for Stability Enhancement of Polyphenols. |
Prundeanu M, Brezoiu AM, Deaconu M, Gradisteanu Pircalabioru G, Lincu D, Matei C, Berger D |
Materials (Basel) |
10.3390/ma14216457 |
2021 |
* |
|
Medical Evaluation of the Antimicrobial Activity of Rose Oil on Some Standard Bacteria Strains and Clinical Isolates. |
Demirel S |
Altern Ther Health Med |
AT6887 |
2021 |
* |
|
The Remarkable Antibiofilm Activity of the Sweet Tooth Mushroom, Hydnum repandum (Agaricomycetes), Displaying Synergetic Interactions with Antibiotics. |
Dizeci N, Karaca B, Onar O, Cihan AC, Akata I, Yildirim O |
Int J Med Mushrooms |
10.1615/IntJMedMushrooms.2021040148 |
2021 |
* |
|
Antimicrobial Potential and Phytochemical Profile of Wild and Cultivated Populations of Thyme (Thymus sp.) Growing in Western Romania. |
Beicu R, Alexa E, Obistioiu D, Cocan I, Imbrea F, Pop G, Circioban D, Moisa C, Lupitu A, Copolovici L, Copolovici DM, Imbrea IM |
Plants (Basel) |
10.3390/plants10091833 |
2021 |
* |
|
Alkaloid profiling and antimicrobial activities of Papaver glaucum and P. decaisnei. |
Jafaar HJ, Isbilen O, Volkan E, Sariyar G |
BMC Res Notes |
10.1186/s13104-021-05762-x |
2021 |
* |
|
Antimicrobial Activity of MgB2 Powders Produced via Reactive Liquid Infiltration Method. |
Padhi SK, Baglieri N, Bonino V, Agostino A, Operti L, Batalu ND, Chifiriuc MC, Popa M, Burdusel M, Grigoroscuta MA, Aldica GV, Radu D, Badica P, Truccato M |
Molecules |
10.3390/molecules26164966 |
2021 |
* |
|
Green synthesis, characterization and bioactivity of biogenic zinc oxide nanoparticles. |
Gur T, Meydan I, Seckin H, Bekmezci M, Sen F |
Environ Res |
10.1016/j.envres.2021.111897 |
2021 |
* |
|
Endophytic Fungi from Alstonia boonei De Wild and Greenwayodendron suaveolens (Engl. and Diels) Verdc. subsp. Suaveolens Possess Inhibitory Activity against Pneumonia Causing Bacteria. |
Demeni PCE, Betote PHD, Kom CW, Tchamgoue EN, Ndedi Moni EDF, Foumane Maniepi JS, Agbor GA, Nyegue MA |
Evid Based Complement Alternat Med |
10.1155/2021/9966323 |
2021 |
* |
|
Chemical composition, antioxidant, and antimicrobial activities of two essential oils from Algerian propolis. |
Boulechfar S, Zellagui A, Asan-Ozusaglam M, Bensouici C, Erenler R, Yildiz I, Tacer S, Boural H, Demirtas I |
Z Naturforsch C J Biosci |
10.1515/znc-2021-0028 |
2021 |
* |
|
Reduced Level of Tear Antimicrobial and Immunomodulatory Proteins as a Possible Reason for Higher Ocular Infections in Diabetic Patients. |
Kallo G, Varga AK, Szabo J, Emri M, Tozser J, Csutak A, Csosz E |
Pathogens |
10.3390/pathogens10070883 |
2021 |
* |
|
An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria. |
Bogiel T, Rzepka M, Gospodarek-Komkowska E |
Antibiotics (Basel) |
10.3390/antibiotics10070875 |
2021 |
* |
|
Phytochemical Profile and Microbiological Activity of Some Plants Belonging to the Fabaceae Family. |
Obistioiu D, Cocan I, Tirziu E, Herman V, Negrea M, Cucerzan A, Neacsu AG, Cozma AL, Nichita I, Hulea A, Radulov I, Alexa E |
Antibiotics (Basel) |
10.3390/antibiotics10060662 |
2021 |
* |
|
Assessing the diversity of bacterial communities from marine sponges and their bioactive compounds. |
Bibi F, Naseer MI, Azhar EI |
Saudi J Biol Sci |
10.1016/j.sjbs.2021.03.042 |
2021 |
* |
|
The Antibacterial Activity of Crude Extracts of Secondary Metabolites from Bacterial Endophytes Associated with Dicoma anomala. |
Makuwa SC, Serepa-Dlamini MH |
Int J Microbiol |
10.1155/2021/8812043 |
2021 |
* |
|
Antimicrobial Activity of Selected Medicinal Plants from a Sub-Saharan African Country against Bacterial Pathogens from Post-Operative Wound Infections. |
Owusu E, Ahorlu MM, Afutu E, Akumwena A, Asare GA |
Med Sci (Basel) |
10.3390/medsci9020023 |
2021 |
* |
|
Mixed Pluronic-Cremophor Polymeric Micelles as Nanocarriers for Poorly Soluble Antibiotics-The Influence on the Antibacterial Activity. |
Tanase MA, Raducan A, Oancea P, Ditu LM, Stan M, Petcu C, Scomoroscenco C, Ninciuleanu CM, Nistor CL, Cinteza LO |
Pharmaceutics |
10.3390/pharmaceutics13040435 |
2021 |
* |
|
Design and evaluation of the antimicrobial properties of ackee seed extract silver nanoparticle film formulations. |
Odeniyi MA, Olusomoka E, Odeniyi OA, Adebayo-Tayo BC |
Polim Med |
10.17219/pim/130388 |
2020 |
* |
|
Annulohypoxylon sp. strain MUS1, an endophytic fungus isolated from Taxus wallichiana Zucc., produces taxol and other bioactive metabolites. |
Gauchan DP, Velez H, Acharya A, Ostman JR, Lunden K, Elfstrand M, Garcia-Gil MR |
3 Biotech |
10.1007/s13205-021-02693-z |
2021 |
* |
|
Design, Synthesis, and Biological Evaluation of Light-Activated Antibiotics. |
Shchelik IS, Tomio A, Gademann K |
ACS Infect Dis |
10.1021/acsinfecdis.1c00015 |
2021 |
* |
|
Jacaranda flower (Jacaranda mimosifolia) as an alternative for antioxidant and antimicrobial use. |
Aguirre-Becerra H, Pineda-Nieto SA, Garcia-Trejo JF, Guevara-Gonzalez RG, Feregrino-Perez AA, Alvarez-Mayorga BL, Rivera Pastrana DM |
Heliyon |
10.1016/j.heliyon.2020.e05802 |
2020 |
* |
|
High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa. |
Li S, She P, Zhou L, Zeng X, Xu L, Liu Y, Chen L, Wu Y |
Front Microbiol |
10.3389/fmicb.2020.591426 |
2020 |
* |
|
Efficacy of Levofloxacin Loaded Nonionic Surfactant Vesicles (Niosomes) in a Model of Pseudomonas aeruginosa Infected Sprague Dawley Rats. |
Jankie S, Johnson J, Adebayo AS, Pillai GK, Pinto Pereira LM |
Adv Pharmacol Pharm Sci |
10.1155/2020/8815969 |
2020 |
* |
|
Green Synthesis, Characterization and Antimicrobial Evaluation of Silver Nanoparticles for an Intracanal Dressing. |
Bruniera JFB, Gabriel-Silva L, Goulart RS, Silva-Sousa YTC, Lara MG, Pitondo-Silva A, Miranda CES |
Braz Dent J |
10.1590/0103-6440202003897 |
2020 |
* |
|
Nutraceutical and antimicrobial potentials of Bambara groundnut (Vigna subterranean): A review. |
Udeh EL, Nyila MA, Kanu SA |
Heliyon |
10.1016/j.heliyon.2020.e05205 |
2020 |
* |
|
'Hairy' root extracts as source for 'green' synthesis of silver nanoparticles and medical applications. |
Kobylinska N, Shakhovsky A, Khainakova O, Klymchuk D, Avdeeva L, Ratushnyak Y, Duplij V, Matvieieva N |
RSC Adv |
10.1039/d0ra07784d |
2020 |
* |
|
Bacillus subtilis TR47II as a source of bioactive lipopeptides against Gram-negative pathogens causing nosocomial infections. |
de Souza Freitas F, Coelho de Assis Lage T, Ayupe BAL, de Paula Siqueira T, de Barros M, Totola MR |
3 Biotech |
10.1007/s13205-020-02459-z |
2020 |
* |
|
The Antibacterial and Anti-biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of Pseudomonas Aeruginosa from Irish Cystic Fibrosis Patients. |
O'Shaughnessy M, McCarron P, Viganor L, McCann M, Devereux M, Howe O |
Antibiotics (Basel) |
10.3390/antibiotics9100674 |
2020 |
* |
|
[Antimicrobial effects of fentanyl and bupivacaine]. |
Kesici S, Demirci M, Kesici U |
Braz J Anesthesiol |
10.1016/j.bjan.2020.04.010 |
2020 |
* |
|
The Regulator PltZ Regulates a Putative ABC Transporter System PltIJKNOP of Pseudomonas aeruginosa ATCC 27853 in Response to the Antimicrobial 2,4-Diacetylphloroglucinol. |
Guo DD, Luo LM, Ma HL, Zhang SP, Xu H, Zhang H, Wang Y, Yuan Y, Wang Z, He YX |
Front Microbiol |
10.3389/fmicb.2020.01423 |
2020 |
* |
|
Diverse Pathway to Obtain Antibacterial and Antifungal Agents Based on Silica Particles Functionalized by Amino and Phenyl Groups with Cu(II) Ion Complexes. |
Tomina VV, Furtat IM, Lebed AP, Kotsyuda SS, Kolev H, Kanuchova M, Behunova DM, Vaclavikova M, Melnyk IV |
ACS Omega |
10.1021/acsomega.0c01335 |
2020 |
* |
|
Synthesis and In Vitro Antimicrobial and Anthelminthic Evaluation of Naphtholic and Phenolic Azo Dyes. |
Adu JK, Amengor CDK, Mohammed Ibrahim N, Amaning-Danquah C, Owusu Ansah C, Gbadago DD, Sarpong-Agyapong J |
J Trop Med |
10.1155/2020/4850492 |
2020 |
* |
|
Influence of a cell salvage washing system and leukocyte reduction filtration on bacterial contamination of canine whole blood ex vivo. |
Hinson WD, Rogovskyy AS, Lawhon SD, Thieman Mankin KM |
Vet Surg |
10.1111/vsu.13410 |
2020 |
* |
|
Zinc(II) Complexes with Amino Acids for Potential Use in Dermatology: Synthesis, Crystal Structures, and Antibacterial Activity. |
Abendrot M, Checinska L, Kusz J, Lisowska K, Zawadzka K, Felczak A, Kalinowska-Lis U |
Molecules |
10.3390/molecules25040951 |
2020 |
* |
|
Colistin-resistant Pseudomonas aeruginosa clinical strains with defective biofilm formation. |
Azimi L, Lari AR |
GMS Hyg Infect Control |
10.3205/dgkh000328 |
2019 |
* |
|
Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics. |
Loupias P, Dechamps-Olivier I, Dupont L, Vanlemmens P, Mullie C, Taudon N, Bouchut A, Dassonville-Klimpt A, Sonnet P |
Pharmaceuticals (Basel) |
10.3390/ph12040160 |
2019 |
* |
|
Investigating The Antimicrobial Activity Of Different Root Canal Filling Pastes In Deciduous Teeth. |
Basir L, Khanehmasjedi M, Khosravi A, Ansarifar S |
Clin Cosmet Investig Dent |
10.2147/CCIDE.S214568 |
2019 |
* |
|
Antibacterial Properties of a Novel Zirconium Phosphate-Glycinediphosphonate Loaded with Either Zinc or Silver. |
Campoccia D, Ravaioli S, Vivani R, Donnadio A, Vischini E, Russo A, Visai L, Arciola CR, Montanaro L, Nocchetti M |
Materials (Basel) |
10.3390/ma12193184 |
2019 |
* |
|
Synthesis, Characterization, and Antimicrobial Activity of Magnesium-Doped Hydroxyapatite Suspensions. |
Predoi D, Iconaru SL, Predoi MV, Stan GE, Buton N |
Nanomaterials (Basel) |
10.3390/nano9091295 |
2019 |
* |
|
Evaluating the potential use of electronic tongue in early identification and diagnosis of bacterial infections. |
Al Ramahi R, Zaid AN, Abu-Khalaf N |
Infect Drug Resist |
10.2147/IDR.S213938 |
2019 |
* |
|
Determination of In Vitro Antimicrobial Activity of Five Sri Lankan Medicinal Plants against Selected Human Pathogenic Bacteria. |
De Zoysa MHN, Rathnayake H, Hewawasam RP, Wijayaratne WMDGB |
Int J Microbiol |
10.1155/2019/7431439 |
2019 |
* |
|
Synthesis and Biological Evaluation of Some Novel S-beta-D-Glucosides of 4-Amino-5-alkyl-1,2,4-triazole-3-thiones Derivatives. |
Aghkand AR, Akbaridilmaghani K, Ghezelbash ZD, Asgharib B |
Acta Chim Slov |
Aghkand-2019-2 |
2019 |
* |
|
Lipase-Responsive Electrospun Theranostic Wound Dressing for Simultaneous Recognition and Treatment of Wound Infection. |
Singh H, Li W, Kazemian MR, Yang R, Yang C, Logsetty S, Liu S |
ACS Appl Bio Mater |
10.1021/acsabm.9b00076 |
2019 |
* |
|
Specificity in the Susceptibilities of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus Clinical Isolates to Six Metal Antimicrobials. |
Gugala N, Vu D, Parkins MD, Turner RJ |
Antibiotics (Basel) |
10.3390/antibiotics8020051 |
2019 |
* |
|
Determination of Antimicrobial Activity of Extracts of Indigenous Wild Mushrooms against Pathogenic Organisms. |
Gebreyohannes G, Nyerere A, Bii C, Berhe Sbhatu D |
Evid Based Complement Alternat Med |
10.1155/2019/6212673 |
2019 |
* |
|
A Comparison of Bacterial Adhesion and Biofilm Formation on Commonly Used Orthopaedic Metal Implant Materials: An In vitro Study. |
Malhotra R, Dhawan B, Garg B, Shankar V, Nag TC |
Indian J Orthop |
10.4103/ortho.IJOrtho_66_18 |
2019 |
* |
|
Chemical Profile, Antibacterial Activity and Antibiotic-Modulating Effect of the Hexanic Zea Mays L. Silk Extract (Poaceae). |
Carvalho ABL, Cruz CA, Freitas CLA, Aguiar JJDS, Nunes PLWS, Lima VMDS, Matias EFF, Muniz DF, Coutinho HDM |
Antibiotics (Basel) |
10.3390/antibiotics8010022 |
2019 |
* |
|
Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains. |
Vargas-Casanova Y, Rodriguez-Mayor AV, Cardenas KJ, Leal-Castro AL, Munoz-Molina LC, Fierro-Medina R, Rivera-Monroy ZJ, Garcia-Castaneda JE |
RSC Adv |
10.1039/c9ra00708c |
2019 |
* |
|
In Vitro Comparison of Antibacterial and Antibiofilm Activities of Selected Fluoroquinolones against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus. |
Masadeh MM, Alzoubi KH, Ahmed WS, Magaji AS |
Pathogens |
10.3390/pathogens8010012 |
2019 |
* |
|
Sterilization protocol for porous dental implants made by Selective Laser Melting. |
Manea A, Bran S, Baciut M, Armencea G, Pop D, Berce P, Vodnar DC, Hedesiu M, Dinu C, Petrutiu A, Tomina D, Baciut G |
Clujul Med |
10.15386/cjmed-987 |
2018 |
* |
|
High-Temperature Short-Time Treatment of Human Milk for Bacterial Count Reduction. |
Klotz D, Schreiner M, Falcone V, Jonas D, Kunze M, Weber A, Fuchs H, Hentschel R |
Front Pediatr |
10.3389/fped.2018.00359 |
2018 |
* |
|
Structure Elucidation and Antimicrobial Activities of Secondary Metabolites from the Flowery Parts of Verbascum mucronatum Lam. |
Kahraman C, Tatli II, Kart D, Ekizoglu M, Akdemir ZS |
Turk J Pharm Sci |
10.4274/tjps.50479 |
2018 |
* |
|
Antimicrobial activity of Terminalia catappa brown leaf extracts against Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853. |
Allyn OQ, Kusumawati E, Nugroho RA |
F1000Res |
10.12688/f1000research.15998.1 |
2018 |
* |
|
Antibiotic Activity of Actinobacteria from the Digestive Tract of Millipede Nedyopus dawydoffiae (Diplopoda). |
Glukhova AA, Karabanova AA, Yakushev AV, Semenyuk II, Boykova YV, Malkina ND, Efimenko TA, Ivankova TD, Terekhova LP, Efremenkova OV |
Antibiotics (Basel) |
10.3390/antibiotics7040094 |
2018 |
* |
|
Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge. |
Maria de Souza Morais S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, Aparecido Salvador E, Rodrigues Franco I, Augusto Pires de Souza G, Henrique Cruvinel da Silva P, Gustavo Nogueira de Almeida L, Prado Rocha R, Carolina Toledo da Cunha Pereira A, Portela Ferreira G, Veras Quelemes P, Pereira de Araujo M, Fornias Sperandio F, Junia de Souza Santos L, Assis Martins Filho O, Cosme Cotta Malaquias L, Felipe Leomil Coelho L |
Vaccine |
10.1016/j.vaccine.2018.08.070 |
2018 |
* |
|
Identification of 4-isopropyl-thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation. |
Elagawany M, Hegazy L, Cao F, Donlin MJ, Rath N, Tavis J, Elgendy B |
RSC Adv |
10.1039/c8ra06297h |
2018 |
* |
|
Oxidative responses and defense mechanism of hyperpigmented P. aeruginosa as characterized by proteomics and metabolomics. |
Thippakorn C, Isarankura-Na-Ayudhya C, Pannengpetch S, Isarankura-Na-Ayudhya P, Schaduangrat N, Nantasenamat C, Prachayasittikul V |
EXCLI J |
10.17179/excli2018-1238 |
2018 |
* |
|
Comparison of Antimicrobial Properties of Silver Nanoparticles Synthesized from Selected Bacteria. |
Peiris MMK, Fernando SSN, Jayaweera PM, Arachchi NDH, Guansekara TDCP |
Indian J Microbiol |
10.1007/s12088-018-0723-3 |
2018 |
* |
|
Prevention of Cross-contamination Risk by Disinfection of Irreversible Hydrocolloid Impression Materials with Ozonated Water. |
Savabi O, Nejatidanesh F, Bagheri KP, Karimi L, Savabi G |
Int J Prev Med |
10.4103/ijpvm.IJPVM_143_16 |
2018 |
* |
|
Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens. |
Vega SC, Martinez DA, Chala MDS, Vargas HA, Rosas JE |
Front Microbiol |
10.3389/fmicb.2018.00329 |
2018 |
* |
|
Chemical and microbiological characterization of tinctures and microcapsules loaded with Brazilian red propolis extract. |
da Cruz Almeida ET, da Silva MCD, Oliveira JMDS, Kamiya RU, Arruda REDS, Vieira DA, Silva VDC, Escodro PB, Basilio-Junior ID, do Nascimento TG |
J Pharm Anal |
10.1016/j.jpha.2017.03.004 |
2017 |
* |
|
A complex hierarchical quorum-sensing circuitry modulates phenazine gene expression in Pseudomonas aeruginosa. |
Abd El-Aziz NK, Abd El-Hamid MI, El-Naenaeey EY |
J Infect Dev Ctries |
10.3855/jidc.8775 |
2018 |
* |
|
Antibacterial, Antitubercular and Antiviral Activity Evaluations of Some Arylidenehydrazide Derivatives Bearing Imidazo[2,1-b]thiazole Moiety. |
Ulusoy Guzeldemirci N, Karaman B, Kucukbasmaci O |
Turk J Pharm Sci |
10.4274/tjps.25743 |
2017 |
* |
|
Chemical constituents of Helichrysum italicum (Roth) G. Don essential oil and their antimicrobial activity against Gram-positive and Gram-negative bacteria, filamentous fungi and Candida albicans. |
Djihane B, Wafa N, Elkhamssa S, Pedro HJ, Maria AE, Mohamed Mihoub Z |
Saudi Pharm J |
10.1016/j.jsps.2016.11.001 |
2016 |
* |
|
Screening for antibacterial and antibiofilm activities in Astragalus angulosus. |
Kanaan H, El-Mestrah M, Sweidan A, As-Sadi F, Bazzal AA, Chokr A |
J Intercult Ethnopharmacol |
10.5455/jice.20161018101720 |
2016 |
* |
|
Evaluation of the role of substrate and albumin on Pseudomonas aeruginosa biofilm morphology through FESEM and FTIR studies on polymeric biomaterials. |
Dutta Sinha S, Chatterjee S, Maiti PK, Tarafdar S, Moulik SP |
Prog Biomater |
10.1007/s40204-017-0061-2 |
2017 |
* |
|
Anti-bacterial efficacy of alcoholic hand rubs in the Kenyan market, 2015. |
Ochwoto M, Muita L, Talaam K, Wanjala C, Ogeto F, Wachira F, Osman S, Kimotho J, Ndegwa L |
Antimicrob Resist Infect Control |
10.1186/s13756-017-0174-3 |
2017 |
* |
|
Benzotriazole-Mediated Synthesis and Antibacterial Activity of Novel N-Acylcephalexins. |
Agha KA, Abo-Dya NE, Ibrahim TS, Abdel-Aal EH, Hegazy WA |
Sci Pharm |
10.3390/scipharm84030484 |
2016 |
* |
|
Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of novel quinoline bearing dihydropyridines. |
Nkosi SM, Anand K, Anandakumar S, Singh S, Chuturgoon AA, Gengan RM |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2016.10.009 |
2016 |
* |
|
Assessment of In vitro Antibacterial Activity and Cytotoxicity Effect of Nigella sativa Oil. |
Ugur AR, Dagi HT, Ozturk B, Tekin G, Findik D |
Pharmacogn Mag |
10.4103/0973-1296.191459 |
2016 |
* |
|
A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Streptococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic Fungi. |
Thomson KS, Thomson GK, Biehle J, Deeb A, Crawford J, Herrera R |
Curr Ther Res Clin Exp |
10.1016/j.curtheres.2016.07.001 |
2016 |
* |
|
Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract. |
Mamun Or Rashida M, Shafiul Islam M, Azizul Haque M, Arifur Rahman M, Tanvir Hossain M, Abdul Hamid M |
Iran J Pharm Res |
|
2016 |
* |
|
Interfacial Stacks of Polymeric Nanofilms on Soft Biological Surfaces that Release Multiple Agents. |
Herron M, Schurr MJ, Murphy CJ, McAnulty JF, Czuprynski CJ, Abbott NL |
ACS Appl Mater Interfaces |
10.1021/acsami.6b08608 |
2016 |
* |
|
Planctomycetes as Novel Source of Bioactive Molecules. |
Graca AP, Calisto R, Lage OM |
Front Microbiol |
10.3389/fmicb.2016.01241 |
2016 |
* |
|
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus. |
Yim J, Smith JR, Barber KE, Hallesy JA, Rybak MJ |
Infect Dis Ther |
10.1007/s40121-016-0121-2 |
2016 |
* |
|
Enhanced osteogenic and selective antibacterial activities on micro-/nano-structured carbon fiber reinforced polyetheretherketone. |
Lu T, Li J, Qian S, Cao H, Ning C, Liu X |
J Mater Chem B |
10.1039/c6tb00268d |
2016 |
* |
|
Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity. |
Grace JL, Huang JX, Cheah SE, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR |
RSC Adv |
10.1039/C5RA24361K |
2016 |
* |
|
Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa. |
Moghoofei M, Fazeli H, Poursina F, Nasr Esfahani B, Moghim S, Vaez H, Hadifar S, Ghasemian Safaei H |
Jundishapur J Microbiol |
10.5812/jjm.25250 |
2015 |
* |
|
Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of nitro-l-arginine methyl ester. |
Panzariu AT, Apotrosoaei M, Vasincu IM, Dragan M, Constantin S, Buron F, Routier S, Profire L, Tuchilus C |
Chem Cent J |
10.1186/s13065-016-0151-6 |
2016 |
* |
|
gamma-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol. |
Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P |
J Inorg Biochem |
10.1016/j.jinorgbio.2016.01.008 |
2016 |
* |
|
In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina. |
Ogidi OC, Oyetayo VO, Akinyele BJ |
Int J Microbiol |
10.1155/2015/106308 |
2015 |
* |
|
Matrix-assisted laser desorption/ionization time-of-flight vs. fast-atom bombardment and electrospray ionization mass spectrometry in the structural characterization of bacterial poly(3-hydroxyalkanoates). |
Impallomeni G, Ballistreri A, Carnemolla GM, Franco D, Guglielmino SP |
Rapid Commun Mass Spectrom |
10.1002/rcm.7168 |
2015 |
* |
|
Aminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods. |
Reynolds-Campbell G, Nicholson A, Christian N, Hardie R, Cook J |
West Indian Med J |
10.7727/wimj.2014.040 |
2015 |
* |
|
In vitro assessment of antibacterial effect of garlic (allium sativum) extracts on pseudomonas aeruginosa. |
Saha SK, Saha S, Hossain MA, Paul SK |
Mymensingh Med J |
|
2015 |
* |
|
Blue Laser Inhibits Bacterial Growth of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. |
de Sousa NT, Santos MF, Gomes RC, Brandino HE, Martinez R, de Jesus Guirro RR |
Photomed Laser Surg |
10.1089/pho.2014.3854 |
2015 |
* |
|
[In vitro comparison of epidural bacteria filters permeability and screening scanning electron microscopy]. |
Sener A, Erkin Y, Sener A, Tasdogen A, Dokumaci E, Elar Z |
Rev Bras Anestesiol |
10.1016/j.bjan.2013.08.004 |
2014 |
* |
|
Antibacterial and antibiofilm activities of polysaccharides, essential oil, and fatty oil extracted from Laurus nobilis growing in Lebanon. |
Chmit M, Kanaan H, Habib J, Abbass M, Mcheik A, Chokr A |
Asian Pac J Trop Med |
10.1016/S1995-7645(14)60288-1 |
2014 |
* |
|
Draft Genome Assembly of Pseudomonas aeruginosa Quality Control Reference Strain Boston 41501. |
Minogue TD, Daligault HE, Davenport KW, Broomall SM, Bruce DC, Chain PS, Coyne SR, Gibbons HS, Jaissle J, Chertkov O, Freitas T, Rosenzweig CN, Xu Y, Johnson SL |
Genome Announc |
10.1128/genomeA.00960-14 |
2014 |
* |
|
Essential oils and herbal extracts as antimicrobial agents in cosmetic emulsion. |
Herman A, Herman AP, Domagalska BW, Mlynarczyk A |
Indian J Microbiol |
10.1007/s12088-012-0329-0 |
2012 |
* |
|
Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. |
Kountouras J, Sofianou D, Gavalas E, Sianou E, Zavos C, Meletis G, Tsiaousi E |
Hippokratia |
|
2012 |
* |
|
Comparative study of antibacterial and antifungal effects of rigid gas permeable contact lens disinfecting solutions. |
Kuzman T, Kutija MB, Kordic R, Popovic-Sui S, Jandrokovic S, Skegro I, Pokupec R |
Coll Antropol |
|
2013 |
* |
|
Comparative study on the antibacterial activity of some flavonoids and their sulfonic derivatives. |
Woznicka E, Kuzniar A, Nowak D, Nykiel E, Kopacz M, Gruszecka J, Golec K |
Acta Pol Pharm |
|
2013 |
* |
|
In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide. |
Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI |
Infect Drug Resist |
10.2147/IDR.S41501 |
2013 |
* |
|
[Comparison of antibacterial activities of Tobramycin inhalation solutions]. |
Pisarev VV |
Antibiot Khimioter |
|
2013 |
* |
|
In vitro evaluation of anti-pathogenic surface coating nanofluid, obtained by combining Fe3O4/C12 nanostructures and 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. |
Anghel I, Limban C, Grumezescu AM, Anghel AG, Bleotu C, Chifiriuc MC |
Nanoscale Res Lett |
10.1186/1556-276X-7-513 |
2012 |
* |
|
Contribution of UVB radiation to bacterial inactivation by natural sunlight. |
Oppezzo OJ |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2012.06.011 |
2012 |
* |
|
Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains. |
Torres IM, Bento EB, Almeida Lda C, de Sa LZ, Lima EM |
Braz J Microbiol |
10.1590/S1517-838220120003000020 |
2012 |
* |
|
Evaluations of the Effects of Extremely Low-Frequency Electromagnetic Fields on Growth and Antibiotic Susceptibility of Escherichia coli and Pseudomonas aeruginosa. |
Segatore B, Setacci D, Bennato F, Cardigno R, Amicosante G, Iorio R |
Int J Microbiol |
10.1155/2012/587293 |
2012 |
* |
|
The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats. |
Gao X, Huang Y, Han Y, Bai CX, Wang G |
Arch Med Sci |
10.5114/aoms.2011.23403 |
2011 |
* |
|
An in vitro and in vivo study on the intensity of adhesion and colonization by Staphylococcus epidermidis and Pseudomonas aeruginosa on originally synthesized biomaterials with different chemical composition and modified surfaces and their effect on expression of TNF-alpha, beta-defensin 2 and IL-10 in tissues. |
Reinis A, Pilmane M, Stunda A, Vetra J, Kroica J, Rostoka D, Salms G, Vostroilovs A, Dons A, Berzina-Cimdina L |
Medicina (Kaunas) |
1110-06e |
2011 |
* |
|
Composition and antimicrobial activity of Seseli globiferum essential oil. |
Janackovic P, Sokovic M, Vujisic L, Vajs V, Vuckovic I, Krivosej Z, Marin PD |
Nat Prod Commun |
|
2011 |
* |
|
Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia. |
Drusano GL, Vanscoy B, Liu W, Fikes S, Brown D, Louie A |
Antimicrob Agents Chemother |
10.1128/AAC.01687-10 |
2011 |
* |
|
Synthesis and antibacterial activity of triphenyltinbenzoate. |
Choudhury MK, Zewdie B |
Indian J Pharm Sci |
10.4103/0250-474X.73923 |
2010 |
* |
|
Candida albicans and Pseudomonas aeruginosa adhesion on soft contact lenses. |
Onurdag FK, Ozkan S, Ozgen S, Olmus H, Abbasoglu U |
Graefes Arch Clin Exp Ophthalmol |
10.1007/s00417-010-1595-3 |
2010 |
* |
|
Antibacterial and antioxidant activity of methanol extract of Evolvulus nummularius. |
Pavithra PS, Sreevidya N, Verma RS |
Indian J Pharmacol |
10.4103/0253-7613.58514 |
2009 |
* |
|
Antimicrobial activity of Acacia mellifera extracts and lupane triterpenes. |
Mutai C, Bii C, Vagias C, Abatis D, Roussis V |
J Ethnopharmacol |
10.1016/j.jep.2009.02.007 |
2009 |
* |
|
Comparison of contact angle measurement and microbial adhesion to solvents for assaying electron donor-electron acceptor (acid-base) properties of bacterial surface. |
Hamadi F, Latrache H |
Colloids Surf B Biointerfaces |
10.1016/j.colsurfb.2008.03.010 |
2008 |
* |
|
Development and validation of an agar diffusion assay for determination of ceftazidime in pharmaceutical preparations. |
Schmidt CA, Carazzo M, Laporta LV, Bittencourt CF, Santos MR, Friedrich M |
J AOAC Int |
|
2008 |
* |
|
Direct quantification of test bacteria in synthetic water-polluted samples by square wave voltammetry and chemometric methods. |
Carpani I, Conti P, Lanteri S, Legnani PP, Leoni E, Tonelli D |
Biosens Bioelectron |
10.1016/j.bios.2007.09.018 |
2007 |
* |
|
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. |
Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mocchegiani F, Rocchi M, Chiodi L, Abbruzzetti A, Saba V, Scalise G, Giacometti A |
Crit Care Med |
10.1097/01.CCM.0000266685.25436.03 |
2007 |
* |
|
The in-vitro antibacterial activity of Annona senegalensis, Securidacca longipendiculata and Steganotaenia araliacea - Ugandan medicinal plants. |
Lino A, Deogracious O |
Afr Health Sci |
10.5555/afhs.2006.6.1.31 |
2006 |
* |
|
Biological activities of some natural compounds from Sideritis sipylea Boiss. |
Logoglu E, Arslan S, Oktemer A, Sakoyan I |
Phytother Res |
10.1002/ptr.1855 |
2006 |
* |
|
Failure of anti-retraction valves and the procedure for between patient flushing: a rationale for chemical control of dental unit waterline contamination. |
Montebugnoli L, Dolci G, Spratt DA, Puttaiah R |
Am J Dent |
|
2005 |
* |
|
Wound healing potential of Cassia fistula on infected albino rat model. |
Senthil Kumar M, Sripriya R, Vijaya Raghavan H, Sehgal PK |
J Surg Res |
10.1016/j.jss.2005.08.025 |
2005 |
* |
|
Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds. |
Kucukbay H, Durmaz R, Orhan E, Gunal S |
Farmaco |
10.1016/S0014-827X(03)00068-5 |
2003 |
* |
|
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group. |
Jones RN, Kugler KC, Erwin ME, Biedenbach DJ, Beach ML, Pfaller MA |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(98)00086-8 |
1999 |
* |
|
The role of Pseudomonas aeruginosa biofilm in the attachment of Acanthamoeba to four types of hydrogel contact lens materials. |
Simmons PA, Tomlinson A, Seal DV |
Optom Vis Sci |
10.1097/00006324-199812000-00007 |
1998 |
* |
|
Antibiotic activity of isoxazolylnaphthoquinone imines on mice infected with Staphylococcus aureus. |
Albesa I, Bogdanov P, Eraso A, Sperandeo NR, de Bertorello MM |
J Appl Bacteriol |
10.1111/j.1365-2672.1995.tb03420.x |
1995 |
* |
|
Imipenem stability in a predried susceptibility panel. |
Daly JS, Deluca BA, Hebert SR, Dodge RA, Soja DT |
J Clin Microbiol |
10.1128/jcm.32.10.2584-2587.1994 |
1994 |
* |
|
Cell Density and Growth Phase as Factors in the Resistance of a Biofilm of Pseudomonas aeruginosa (ATCC 27853) to Iodine. |
Brown ML, Gauthier JJ |
Appl Environ Microbiol |
10.1128/aem.59.7.2320-2322.1993 |
1993 |
* |
|
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. |
Nickolai DJ, Lammel CJ, Byford BA, Morris JH, Kaplan EB, Hadley WK, Brooks GF |
J Clin Microbiol |
10.1128/jcm.21.3.366-370.1985 |
1985 |
* |
|
Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin. |
Rudrik JT, Cavalieri SJ, Britt EM |
J Clin Microbiol |
10.1128/jcm.21.3.332-334.1985 |
1985 |
* |
|
Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacin. |
Shungu DL, Tutlane V, Gadebusch HH |
J Clin Microbiol |
10.1128/jcm.18.4.988-991.1983 |
1983 |
* |
|
Evaluations of antimicrobial susceptibility test proficiency by the College of American Pathologists Survey program. A clarification of quality control recommendations. |
Jones RN, Edson DC, Marymont JV |
Am J Clin Pathol |
10.1093/ajcp/78.2.168 |
1982 |
* |
|
Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies. |
Acar Cevik U, Isik A, Evren AE, Kapusiz O, Gul UD, Ozkay Y, Kaplancikli ZA |
SAR QSAR Environ Res |
10.1080/1062936X.2022.2149620 |
2022 |
* |
|
New Alkylpyridinium Anthraquinone, Isocoumarin, C-Glucosyl Resorcinol Derivative and Prenylated Pyranoxanthones from the Culture of a Marine Sponge-Associated Fungus, Aspergillus stellatus KUFA 2017. |
Machado FP, Rodrigues IC, Gales L, Pereira JA, Costa PM, Dethoup T, Mistry S, Silva AMS, Vasconcelos V, Kijjoa A |
Mar Drugs |
10.3390/md20110672 |
2022 |
* |
|
Antimicrobial Activity of Silver and Gold Nanoparticles Prepared by Photoreduction Process with Leaves and Fruit Extracts of Plinia cauliflora and Punica granatum. |
Franzolin MR, Courrol DDS, Silva FRO, Courrol LC |
Molecules |
10.3390/molecules27206860 |
2022 |
* |
|
Essential Oils as Antimicrobial Active Substances in Wound Dressings. |
Gheorghita D, Grosu E, Robu A, Ditu LM, Deleanu IM, Gradisteanu Pircalabioru G, Raiciu AD, Bita AI, Antoniac A, Antoniac VI |
Materials (Basel) |
10.3390/ma15196923 |
2022 |
* |
|
Photocatalytic and Antimicrobial Activities of Biosynthesized Silver Nanoparticles Using Cytobacillus firmus. |
Saied E, Hashem AH, Ali OM, Selim S, Almuhayawi MS, Elbahnasawy MA |
Life (Basel) |
10.3390/life12091331 |
2022 |
* |
|
New Pyrazolo-Benzimidazole Mannich Bases with Antimicrobial and Antibiofilm Activities. |
Zalaru C, Dumitrascu F, Draghici C, Tarcomnicu I, Marinescu M, Nitulescu GM, Tatia R, Moldovan L, Popa M, Chifiriuc MC |
Antibiotics (Basel) |
10.3390/antibiotics11081094 |
2022 |
* |
|
Phenolic Secondary Metabolites and Antiradical and Antibacterial Activities of Different Extracts of Usnea barbata (L.) Weber ex F.H.Wigg from Calimani Mountains, Romania. |
Popovici V, Bucur L, Gird CE, Popescu A, Matei E, Cozaru GC, Schroder V, Ozon EA, Fita AC, Lupuliasa D, Aschie M, Caraiane A, Botnarciuc M, Badea V |
Pharmaceuticals (Basel) |
10.3390/ph15070829 |
2022 |
* |
|
Catalytic Reduction of Dyes and Antibacterial Activity of AgNPs@Zn@Alginate Composite Aerogel Beads. |
Benali F, Boukoussa B, Benkhedouda NE, Cheddad A, Issam I, Iqbal J, Hachemaoui M, Abboud M, Mokhtar A |
Polymers (Basel) |
10.3390/polym14224829 |
2022 |
* |
|
Characteristics of Ag-incorporated bioactive glasses prepared by a modified sol-gel method with a shortened synthesis time and without the use of catalysts. |
Hoa BT, Phuc LH, Hien NQ, Vinh LK, Tien NA, Hiep DT, Vi VT, Ly DN, Long NV, Hieu TT, Linh LV, Minh NT, Xuan Vuong B |
RSC Adv |
10.1039/d2ra05671b |
2022 |
* |
|
Effect of Culture Conditions on Fatty Acid Profiles of Bacteria and Lipopolysaccharides of the Genus Pseudomonas-GC-MS Analysis on Ionic Liquid-Based Column. |
Mezo E, Hartmann-Balogh F, Madaraszne Horvath I, Bufa A, Marosvolgyi T, Kocsis B, Makszin L |
Molecules |
10.3390/molecules27206930 |
2022 |
* |
|
Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis. |
Sihotang TSU, Widodo ADW, Endraswari PD |
Ann Med Surg (Lond) |
10.1016/j.amsu.2022.104674 |
2022 |
* |
|
The Ability of Nuclease-Resistant RNA Aptamer against Streptococcus suis Serotype 2, Strain P1/7 to Reduce Biofilm Formation In Vitro. |
Matchawong A, Srisawat C, Sangboonruang S, Tharinjaroen CS |
Molecules |
10.3390/molecules27123894 |
2022 |
* |
Name and taxonomic classification
Morphology
Culture and growth conditions
Physiology and metabolism
Isolation, sampling and environmental information
Safety information
Sequence information
Genome-based predictions
External links
References
ENA
tax ID